Ranking · Research
Publications, last 12 months
PubMed records matching the cancer’s query with a publication date in the last 12 months.
Computedci-pubs-12m-v1unit: counthigher = betterAll metrics
| Rank | Δ | Cancer | Publications, last 12 months (count) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Conventional Osteosarcoma | 92,561 | 100 | Medium confidence | pubmed | inputs
ranking row 2587569 |
| 2 | = | Gastric Mixed Adenocarcinoma | 61,485 | 100 | Medium confidence | pubmed | inputs
ranking row 2587570 |
| 3 | = | Malignant Breast Neoplasm | 27,734 | 99.9 | Medium confidence | pubmed | inputs
ranking row 2587571 |
| 4 | = | Breast Carcinoma | 27,661 | 99.9 | Medium confidence | pubmed | inputs
ranking row 2587572 |
| 5 | = | Childhood Breast Carcinoma | 27,257 | 99.8 | Medium confidence | pubmed | inputs
ranking row 2587573 |
| 6 | = | Gastric Intestinal-Type Adenocarcinoma | 24,994 | 99.8 | Medium confidence | pubmed | inputs
ranking row 2587574 |
| 7 | = | Carcinoma | 23,487 | 99.7 | Medium confidence | pubmed | inputs
ranking row 2587575 |
| 8 | = | Lung Carcinoma | 19,676 | 99.7 | Medium confidence | pubmed | inputs
ranking row 2587576 |
| 9 | = | Malignant Lung Neoplasm | 19,659 | 99.7 | Medium confidence | pubmed | inputs
ranking row 2587577 |
| 10 | = | Adenocarcinoma | 15,455 | 99.6 | Medium confidence | pubmed | inputs
ranking row 2587578 |
| 11 | = | Colorectal Carcinoma | 14,407 | 99.6 | Medium confidence | pubmed | inputs
ranking row 2587579 |
| 12 | = | Malignant Colorectal Neoplasm | 14,135 | 99.5 | Medium confidence | pubmed | inputs
ranking row 2587580 |
| 13 | = | Gastric Diffuse Adenocarcinoma | 10,970 | 99.5 | Medium confidence | pubmed | inputs
ranking row 2587581 |
| 14 | = | Malignant Prostate Neoplasm | 10,892 | 99.4 | Medium confidence | pubmed | inputs
ranking row 2587582 |
| 15 | = | Primitive Neuroectodermal Tumor | 10,757 | 99.4 | Medium confidence | pubmed | inputs
ranking row 2587583 |
| 16 | = | Prostate Carcinoma | 10,747 | 99.3 | Medium confidence | pubmed | inputs
ranking row 2587584 |
| 17 | = | Endemic Burkitt Lymphoma | 8,895 | 99.3 | Medium confidence | pubmed | inputs
ranking row 2587585 |
| 18 | = | Differentiating Neuroblastoma | 7,315 | 99.3 | Medium confidence | pubmed | inputs
ranking row 2587586 |
| 19 | = | Grade 3 Follicular Lymphoma | 7,106 | 99.2 | Medium confidence | pubmed | inputs
ranking row 2587587 |
| 20 | = | Malignant Gastric Neoplasm | 6,759 | 99.2 | Medium confidence | pubmed | inputs
ranking row 2587588 |
| 21 | = | Gastric Carcinoma | 6,742 | 99.1 | Medium confidence | pubmed | inputs
ranking row 2587589 |
| 22 | = | Cervical Carcinoma | 5,795 | 99.1 | Medium confidence | pubmed | inputs
ranking row 2587590 |
| 23 | = | Malignant Cervical Neoplasm | 5,707 | 99 | Medium confidence | pubmed | inputs
ranking row 2587591 |
| 24 | = | Pancreatic Carcinoma | 5,432 | 99 | Medium confidence | pubmed | inputs
ranking row 2587592 |
| 25 | = | Malignant Pancreatic Neoplasm | 5,402 | 99 | Medium confidence | pubmed | inputs
ranking row 2587593 |
| 26 | = | Splenic Hodgkin Lymphoma | 5,358 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2587594 |
| 27 | = | Adult Glioblastoma | 5,286 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2587596 |
| 27 | = | Childhood Glioblastoma | 5,286 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2587597 |
| 27 | = | Glioblastoma | 5,286 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2587595 |
| 30 | = | Malignant Ovarian Neoplasm | 5,208 | 98.7 | Medium confidence | pubmed | inputs
ranking row 2587598 |
| 31 | = | Hepatocellular Carcinoma | 5,018 | 98.7 | Medium confidence | pubmed | inputs
ranking row 2587599 |
| 32 | = | Leukemia | 4,936 | 98.6 | Medium confidence | pubmed | inputs
ranking row 2587600 |
| 33 | = | Bronchogenic Carcinoma | 4,875 | 98.6 | Medium confidence | pubmed | inputs
ranking row 2587601 |
| 34 | = | Squamous Cell Carcinoma | 4,610 | 98.6 | Medium confidence | pubmed | inputs
ranking row 2587602 |
| 35 | = | Lung Non-Small Cell Carcinoma | 4,343 | 98.5 | Medium confidence | pubmed | inputs
ranking row 2587603 |
| 36 | = | Thyroid Gland Carcinoma | 3,980 | 98.5 | Medium confidence | pubmed | inputs
ranking row 2587604 |
| 37 | = | Bladder Carcinoma | 3,911 | 98.4 | Medium confidence | pubmed | inputs
ranking row 2587605 |
| 38 | = | Malignant Bladder Neoplasm | 3,848 | 98.4 | Medium confidence | pubmed | inputs
ranking row 2587606 |
| 39 | = | Childhood Bladder Carcinoma | 3,774 | 98.3 | Medium confidence | pubmed | inputs
ranking row 2587607 |
| 40 | = | B-Cell Non-Hodgkin Lymphoma | 3,751 | 98.3 | Medium confidence | pubmed | inputs
ranking row 2587608 |
| 41 | = | B-Cell Malignant Neoplasm | 3,664 | 98.3 | Medium confidence | pubmed | inputs
ranking row 2587609 |
| 42 | = | Lymphoma | 3,442 | 98.2 | Medium confidence | pubmed | inputs
ranking row 2587610 |
| 43 | = | Grade 2 Follicular Lymphoma | 3,441 | 98.2 | Medium confidence | pubmed | inputs
ranking row 2587611 |
| 44 | = | Pancreatic Ductal Adenocarcinoma | 3,337 | 98.1 | Medium confidence | pubmed | inputs
ranking row 2587612 |
| 45 | = | Malignant Liver Neoplasm | 3,252 | 98.1 | Medium confidence | pubmed | inputs
ranking row 2587613 |
| 46 | = | Adult Liver Carcinoma | 3,196 | 98 | Medium confidence | pubmed | inputs
ranking row 2587614 |
| 47 | = | Colon Carcinoma | 3,055 | 98 | Medium confidence | pubmed | inputs
ranking row 2587615 |
| 48 | = | Malignant Head and Neck Neoplasm | 3,028 | 98 | Medium confidence | pubmed | inputs
ranking row 2587616 |
| 49 | = | Grade 1 Follicular Lymphoma | 3,017 | 97.9 | Medium confidence | pubmed | inputs
ranking row 2587617 |
| 50 | = | Melanoma | 3,010 | 97.9 | Medium confidence | pubmed | inputs
ranking row 2587618 |
| 51 | = | Malignant Neck Neoplasm | 2,989 | 97.8 | Medium confidence | pubmed | inputs
ranking row 2587619 |
| 52 | = | Malignant Colon Neoplasm | 2,956 | 97.8 | Medium confidence | pubmed | inputs
ranking row 2587620 |
| 53 | = | Sarcoma | 2,831 | 97.7 | Medium confidence | pubmed | inputs
ranking row 2587621 |
| 54 | = | Malignant Thyroid Gland Neoplasm | 2,700 | 97.7 | Medium confidence | pubmed | inputs
ranking row 2587622 |
| 55 | = | Myeloid Leukemia | 2,680 | 97.6 | Medium confidence | pubmed | inputs
ranking row 2587623 |
| 56 | = | Endometrial Carcinoma | 2,611 | 97.6 | Medium confidence | pubmed | inputs
ranking row 2587624 |
| 57 | = | Childhood Acute Myeloid Leukemia | 2,575 | 97.6 | Medium confidence | pubmed | inputs
ranking row 2587625 |
| 58 | = | Non-Hodgkin Lymphoma | 2,542 | 97.5 | Medium confidence | pubmed | inputs
ranking row 2587626 |
| 59 | = | Adult Acute Myeloid Leukemia | 2,541 | 97.5 | Medium confidence | pubmed | inputs
ranking row 2587627 |
| 60 | = | Malignant Rectal Neoplasm | 2,511 | 97.4 | Medium confidence | pubmed | inputs
ranking row 2587628 |
| 61 | = | Rectal Carcinoma | 2,491 | 97.4 | Medium confidence | pubmed | inputs
ranking row 2587629 |
| 62 | = | Childhood Rectal Carcinoma | 2,441 | 97.3 | Medium confidence | pubmed | inputs
ranking row 2587630 |
| 63 | = | Malignant Skin Neoplasm | 2,401 | 97.3 | Medium confidence | pubmed | inputs
ranking row 2587631 |
| 64 | = | Esophageal Carcinoma | 2,284 | 97.3 | Medium confidence | pubmed | inputs
ranking row 2587632 |
| 65 | = | Amyloidosis | 2,267 | 97.2 | Medium confidence | pubmed | inputs
ranking row 2587633 |
| 66 | = | Malignant Endometrial Neoplasm | 2,210 | 97.2 | Medium confidence | pubmed | inputs
ranking row 2587634 |
| 67 | = | Acute Myeloid Leukemia | 2,202 | 97.1 | Medium confidence | pubmed | inputs
ranking row 2587635 |
| 68 | = | Malignant Esophageal Neoplasm | 2,128 | 97.1 | Medium confidence | pubmed | inputs
ranking row 2587636 |
| 69 | = | Triple-Negative Breast Carcinoma | 2,107 | 97 | Medium confidence | pubmed | inputs
ranking row 2587637 |
| 70 | = | Childhood Esophageal Carcinoma | 2,073 | 97 | Medium confidence | pubmed | inputs
ranking row 2587638 |
| 71 | = | Adult Hodgkin Lymphoma | 2,057 | 96.9 | Medium confidence | pubmed | inputs
ranking row 2587639 |
| 72 | = | Childhood Hodgkin Lymphoma | 2,050 | 96.9 | Medium confidence | pubmed | inputs
ranking row 2587640 |
| 73 | = | Diffuse Large B-Cell Lymphoma | 2,044 | 96.9 | Medium confidence | pubmed | inputs
ranking row 2587641 |
| 74 | = | Breast Ductal Carcinoma | 2,012 | 96.8 | Medium confidence | pubmed | inputs
ranking row 2587642 |
| 75 | = | Adult Diffuse Large B-Cell Lymphoma | 1,934 | 96.8 | Medium confidence | pubmed | inputs
ranking row 2587643 |
| 75 | = | Childhood Diffuse Large B-Cell Lymphoma | 1,934 | 96.8 | Medium confidence | pubmed | inputs
ranking row 2587644 |
| 77 | = | Childhood Osteosarcoma | 1,870 | 96.7 | Medium confidence | pubmed | inputs
ranking row 2587645 |
| 78 | = | Lymphoid Leukemia | 1,817 | 96.6 | Medium confidence | pubmed | inputs
ranking row 2587646 |
| 79 | = | Oral Cavity Squamous Cell Carcinoma | 1,758 | 96.6 | Medium confidence | pubmed | inputs
ranking row 2587647 |
| 80 | = | Renal Cell Carcinoma | 1,753 | 96.6 | Medium confidence | pubmed | inputs
ranking row 2587648 |
| 81 | = | Childhood Neuroblastoma | 1,738 | 96.5 | Medium confidence | pubmed | inputs
ranking row 2587649 |
| 82 | = | Multiple Myeloma | 1,734 | 96.5 | Medium confidence | pubmed | inputs
ranking row 2587650 |
| 83 | = | Urothelial Carcinoma | 1,690 | 96.4 | Medium confidence | pubmed | inputs
ranking row 2587651 |
| 84 | = | Childhood Malignant Neoplasm | 1,664 | 96.4 | Medium confidence | pubmed | inputs
ranking row 2587652 |
| 85 | = | Undifferentiated Neuroblastoma | 1,662 | 96.3 | Medium confidence | pubmed | inputs
ranking row 2587653 |
| 86 | = | Malignant Lip and Oral Cavity Neoplasm | 1,586 | 96.3 | Medium confidence | pubmed | inputs
ranking row 2587654 |
| 87 | = | Lip and Oral Cavity Carcinoma | 1,582 | 96.2 | Medium confidence | pubmed | inputs
ranking row 2587655 |
| 88 | = | Clear Cell Renal Cell Carcinoma | 1,563 | 96.2 | Medium confidence | pubmed | inputs
ranking row 2587656 |
| 89 | = | Lung Adenocarcinoma | 1,393 | 96.2 | Medium confidence | pubmed | inputs
ranking row 2587657 |
| 90 | = | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 1,354 | 96.1 | Medium confidence | pubmed | inputs
ranking row 2587658 |
| 91 | = | Castration-Resistant Prostate Carcinoma | 1,325 | 96.1 | Medium confidence | pubmed | inputs
ranking row 2587659 |
| 92 | = | Childhood Non-Hodgkin Lymphoma | 1,260 | 96 | Medium confidence | pubmed | inputs
ranking row 2587660 |
| 93 | = | Adult Non-Hodgkin Lymphoma | 1,256 | 96 | Medium confidence | pubmed | inputs
ranking row 2587661 |
| 94 | = | Head and Neck Squamous Cell Carcinoma | 1,217 | 95.9 | Medium confidence | pubmed | inputs
ranking row 2587662 |
| 95 | = | Acute Lymphoblastic Leukemia | 1,209 | 95.9 | Medium confidence | pubmed | inputs
ranking row 2587663 |
| 96 | = | Poorly Differentiated Neuroblastoma | 1,115 | 95.9 | Medium confidence | pubmed | inputs
ranking row 2587664 |
| 97 | = | Osteosarcoma | 955 | 95.8 | Medium confidence | pubmed | inputs
ranking row 2587665 |
| 98 | = | Skin Basal Cell Carcinoma | 954 | 95.8 | Medium confidence | pubmed | inputs
ranking row 2587666 |
| 99 | = | Childhood Acute Lymphoblastic Leukemia | 947 | 95.7 | Medium confidence | pubmed | inputs
ranking row 2587667 |
| 100 | = | Gastric Adenocarcinoma | 926 | 95.7 | Medium confidence | pubmed | inputs
ranking row 2587668 |
| 101 | = | Childhood Myelodysplastic Syndrome | 920 | 95.6 | Medium confidence | pubmed | inputs
ranking row 2587669 |
| 102 | = | Adult Acute Lymphoblastic Leukemia | 913 | 95.6 | Medium confidence | pubmed | inputs
ranking row 2587670 |
| 103 | = | Myeloproliferative Neoplasm | 907 | 95.6 | Medium confidence | pubmed | inputs
ranking row 2587671 |
| 104 | = | Esophageal Squamous Cell Carcinoma | 895 | 95.5 | Medium confidence | pubmed | inputs
ranking row 2587672 |
| 105 | = | Intrahepatic Cholangiocarcinoma | 894 | 95.5 | Medium confidence | pubmed | inputs
ranking row 2587673 |
| 106 | = | Cholangiocarcinoma | 892 | 95.4 | Medium confidence | pubmed | inputs
ranking row 2587674 |
| 107 | = | Kidney Carcinoma | 862 | 95.4 | Medium confidence | pubmed | inputs
ranking row 2587675 |
| 108 | = | Cutaneous Melanoma | 852 | 95.3 | Medium confidence | pubmed | inputs
ranking row 2587676 |
| 109 | = | Malignant Digestive System Neoplasm | 827 | 95.3 | Medium confidence | pubmed | inputs
ranking row 2587677 |
| 110 | = | Soft Tissue Sarcoma | 816 | 95.2 | Medium confidence | pubmed | inputs
ranking row 2587678 |
| 111 | = | Adult Soft Tissue Sarcoma | 805 | 95.2 | Medium confidence | pubmed | inputs
ranking row 2587679 |
| 111 | = | Childhood Soft Tissue Sarcoma | 805 | 95.2 | Medium confidence | pubmed | inputs
ranking row 2587680 |
| 111 | = | Ovarian Serous Adenocarcinoma | 805 | 95.2 | Medium confidence | pubmed | inputs
ranking row 2587681 |
| 114 | = | Lung Squamous Cell Carcinoma | 760 | 95.1 | Medium confidence | pubmed | inputs
ranking row 2587682 |
| 115 | = | Malignant Brain Neoplasm | 716 | 95 | Medium confidence | pubmed | inputs
ranking row 2587683 |
| 116 | = | Mediastinal Hodgkin Lymphoma | 706 | 95 | Medium confidence | pubmed | inputs
ranking row 2587684 |
| 117 | = | Pancreatic Adenocarcinoma | 699 | 94.9 | Medium confidence | pubmed | inputs
ranking row 2587685 |
| 118 | = | Malignant Kidney Neoplasm | 697 | 94.9 | Medium confidence | pubmed | inputs
ranking row 2587686 |
| 119 | = | Myelodysplastic Syndrome | 688 | 94.9 | Medium confidence | pubmed | inputs
ranking row 2587687 |
| 120 | = | Invasive Breast Carcinoma | 684 | 94.8 | Medium confidence | pubmed | inputs
ranking row 2587688 |
| 121 | = | Adult Myelodysplastic Syndrome | 681 | 94.8 | Medium confidence | pubmed | inputs
ranking row 2587689 |
| 122 | = | Acute Leukemia | 679 | 94.7 | Medium confidence | pubmed | inputs
ranking row 2587690 |
| 123 | = | Papillary Adenocarcinoma | 661 | 94.7 | Medium confidence | pubmed | inputs
ranking row 2587691 |
| 124 | = | Thyroid Gland Papillary Carcinoma | 649 | 94.6 | Medium confidence | pubmed | inputs
ranking row 2587692 |
| 125 | = | Breast Ductal Carcinoma In Situ | 639 | 94.6 | Medium confidence | pubmed | inputs
ranking row 2587693 |
| 126 | = | Nasopharyngeal Carcinoma | 597 | 94.5 | Medium confidence | pubmed | inputs
ranking row 2587694 |
| 127 | = | Early Stage Breast Carcinoma | 588 | 94.5 | Medium confidence | pubmed | inputs
ranking row 2587695 |
| 128 | = | Peripheral Primitive Neuroectodermal Tumor | 582 | 94.5 | Medium confidence | pubmed | inputs
ranking row 2587696 |
| 129 | = | Lung Small Cell Carcinoma | 581 | 94.4 | Medium confidence | pubmed | inputs
ranking row 2587697 |
| 130 | = | Neuroblastoma | 580 | 94.4 | Medium confidence | pubmed | inputs
ranking row 2587698 |
| 131 | = | Brain Stem Glioblastoma | 578 | 94.3 | Medium confidence | pubmed | inputs
ranking row 2587699 |
| 132 | = | Malignant Glioma | 576 | 94.3 | Medium confidence | pubmed | inputs
ranking row 2587700 |
| 133 | = | Skin Carcinoma | 575 | 94.2 | Medium confidence | pubmed | inputs
ranking row 2587701 |
| 134 | = | HER2-Positive Breast Carcinoma | 568 | 94.2 | Medium confidence | pubmed | inputs
ranking row 2587703 |
| 134 | = | Transitional Cell Carcinoma | 568 | 94.2 | Medium confidence | pubmed | inputs
ranking row 2587702 |
| 136 | = | Hereditary Malignant Neoplasm | 562 | 94.1 | Medium confidence | pubmed | inputs
ranking row 2587704 |
| 137 | = | Oropharyngeal Carcinoma | 560 | 94.1 | Medium confidence | pubmed | inputs
ranking row 2587705 |
| 138 | = | Gallbladder Carcinoma | 547 | 94 | Medium confidence | pubmed | inputs
ranking row 2587707 |
| 138 | = | T-Cell Non-Hodgkin Lymphoma | 547 | 94 | Medium confidence | pubmed | inputs
ranking row 2587706 |
| 140 | = | Adult Rhabdomyosarcoma | 545 | 93.9 | Medium confidence | pubmed | inputs
ranking row 2587708 |
| 140 | = | Childhood Rhabdomyosarcoma | 545 | 93.9 | Medium confidence | pubmed | inputs
ranking row 2587709 |
| 142 | = | Invasive Breast Carcinoma of No Special Type | 535 | 93.9 | Medium confidence | pubmed | inputs
ranking row 2587710 |
| 143 | = | Primary Brain Tumor | 507 | 93.8 | Medium confidence | pubmed | inputs
ranking row 2587711 |
| 144 | = | Malignant Oropharyngeal Neoplasm | 506 | 93.8 | Medium confidence | pubmed | inputs
ranking row 2587712 |
| 145 | = | Adult Medulloblastoma | 503 | 93.7 | Medium confidence | pubmed | inputs
ranking row 2587713 |
| 145 | = | Childhood Medulloblastoma | 503 | 93.7 | Medium confidence | pubmed | inputs
ranking row 2587714 |
| 147 | = | Anaplastic Lymphoma | 489 | 93.6 | Medium confidence | pubmed | inputs
ranking row 2587715 |
| 148 | = | Neuroendocrine Carcinoma | 477 | 93.6 | Medium confidence | pubmed | inputs
ranking row 2587716 |
| 149 | = | Laryngeal Carcinoma | 471 | 93.5 | Medium confidence | pubmed | inputs
ranking row 2587717 |
| 150 | = | Malignant Gallbladder Neoplasm | 470 | 93.5 | Medium confidence | pubmed | inputs
ranking row 2587718 |
| 151 | = | Adult Leiomyosarcoma | 469 | 93.5 | Medium confidence | pubmed | inputs
ranking row 2587719 |
| 151 | = | Childhood Leiomyosarcoma | 469 | 93.5 | Medium confidence | pubmed | inputs
ranking row 2587720 |
| 153 | = | Chronic Lymphocytic Leukemia | 462 | 93.4 | Medium confidence | pubmed | inputs
ranking row 2587721 |
| 153 | = | Colon Adenocarcinoma | 462 | 93.4 | Medium confidence | pubmed | inputs
ranking row 2587722 |
| 155 | = | Invasive Carcinoma | 456 | 93.3 | Medium confidence | pubmed | inputs
ranking row 2587723 |
| 156 | = | Malignant Biliary Tract Neoplasm | 454 | 93.2 | Medium confidence | pubmed | inputs
ranking row 2587724 |
| 157 | = | Malignant Bone Neoplasm | 451 | 93.2 | Medium confidence | pubmed | inputs
ranking row 2587725 |
| 158 | = | Adult Liposarcoma | 442 | 93.2 | Medium confidence | pubmed | inputs
ranking row 2587726 |
| 158 | = | Childhood Liposarcoma | 442 | 93.2 | Medium confidence | pubmed | inputs
ranking row 2587727 |
| 160 | = | Prostate Adenocarcinoma | 435 | 93.1 | Medium confidence | pubmed | inputs
ranking row 2587728 |
| 161 | = | Endometrial Clear Cell Adenocarcinoma | 430 | 93 | Medium confidence | pubmed | inputs
ranking row 2587729 |
| 162 | = | Colorectal Adenocarcinoma | 427 | 93 | Medium confidence | pubmed | inputs
ranking row 2587730 |
| 163 | = | Thyroid Gland Medullary Carcinoma | 418 | 92.9 | Medium confidence | pubmed | inputs
ranking row 2587731 |
| 164 | = | Carcinomatosis | 416 | 92.9 | Medium confidence | pubmed | inputs
ranking row 2587732 |
| 165 | = | Renal Pelvis and Ureter Urothelial Carcinoma | 415 | 92.8 | Medium confidence | pubmed | inputs
ranking row 2587733 |
| 166 | = | Malignant Laryngeal Neoplasm | 412 | 92.8 | Medium confidence | pubmed | inputs
ranking row 2587734 |
| 167 | = | High-Grade Serous Ovarian Cancer | 402 | 92.8 | Medium confidence | pubmed | inputs
ranking row 2587735 |
| 168 | = | Renal Pelvis and Ureter Carcinoma | 397 | 92.7 | Medium confidence | pubmed | inputs
ranking row 2587736 |
| 169 | = | Central Nervous System Lymphoma | 395 | 92.7 | Medium confidence | pubmed | inputs
ranking row 2587737 |
| 170 | = | Kidney Wilms Tumor | 392 | 92.6 | Medium confidence | pubmed | inputs
ranking row 2587738 |
| 170 | = | Oropharyngeal Squamous Cell Carcinoma | 392 | 92.6 | Medium confidence | pubmed | inputs
ranking row 2587739 |
| 172 | = | Malignant Female Reproductive System Neoplasm | 387 | 92.5 | Medium confidence | pubmed | inputs
ranking row 2587740 |
| 173 | = | Adult Angiosarcoma | 379 | 92.5 | Medium confidence | pubmed | inputs
ranking row 2587741 |
| 174 | = | Childhood Angiosarcoma | 378 | 92.5 | Medium confidence | pubmed | inputs
ranking row 2587742 |
| 175 | = | Luminal A Breast Carcinoma | 373 | 92.4 | Medium confidence | pubmed | inputs
ranking row 2587743 |
| 176 | = | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 372 | 92.4 | Medium confidence | pubmed | inputs
ranking row 2587744 |
| 177 | = | Rectal Adenocarcinoma | 370 | 92.3 | Medium confidence | pubmed | inputs
ranking row 2587745 |
| 178 | = | Invasive Malignant Neoplasm | 369 | 92.3 | Medium confidence | pubmed | inputs
ranking row 2587746 |
| 179 | = | Esophageal Adenocarcinoma | 365 | 92.2 | Medium confidence | pubmed | inputs
ranking row 2587747 |
| 180 | = | Non-Muscle Invasive Bladder Carcinoma | 364 | 92.2 | Medium confidence | pubmed | inputs
ranking row 2587748 |
| 181 | = | Primary Central Nervous System Lymphoma | 361 | 92.2 | Medium confidence | pubmed | inputs
ranking row 2587749 |
| 182 | = | Childhood Kidney Wilms Tumor | 355 | 92.1 | Medium confidence | pubmed | inputs
ranking row 2587751 |
| 182 | = | Malignant Testicular Germ Cell Tumor | 355 | 92.1 | Medium confidence | pubmed | inputs
ranking row 2587750 |
| 182 | = | Malignant Testicular Neoplasm | 355 | 92.1 | Medium confidence | pubmed | inputs
ranking row 2587752 |
| 185 | = | Ovarian Carcinoma | 353 | 92 | Medium confidence | pubmed | inputs
ranking row 2587753 |
| 186 | = | Carcinoma In Situ | 347 | 91.9 | Medium confidence | pubmed | inputs
ranking row 2587754 |
| 187 | = | Classic Hodgkin Lymphoma | 346 | 91.9 | Medium confidence | pubmed | inputs
ranking row 2587755 |
| 188 | = | Second Primary Malignant Neoplasm | 333 | 91.8 | Medium confidence | pubmed | inputs
ranking row 2587756 |
| 189 | = | Luminal B Breast Carcinoma | 330 | 91.8 | Medium confidence | pubmed | inputs
ranking row 2587757 |
| 190 | = | Early Gastric Carcinoma | 328 | 91.8 | Medium confidence | pubmed | inputs
ranking row 2587758 |
| 191 | = | Hodgkin Lymphoma | 310 | 91.7 | Medium confidence | pubmed | inputs
ranking row 2587759 |
| 192 | = | Anal Carcinoma | 308 | 91.7 | Medium confidence | pubmed | inputs
ranking row 2587760 |
| 193 | = | Differentiated Thyroid Gland Carcinoma | 305 | 91.6 | Medium confidence | pubmed | inputs
ranking row 2587761 |
| 194 | = | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 302 | 91.6 | Medium confidence | pubmed | inputs
ranking row 2587762 |
| 195 | = | Cystadenocarcinoma | 300 | 91.5 | Medium confidence | pubmed | inputs
ranking row 2587763 |
| 196 | = | Paget Disease | 298 | 91.5 | Medium confidence | pubmed | inputs
ranking row 2587764 |
| 197 | = | Basal Cell Carcinoma | 296 | 91.5 | Medium confidence | pubmed | inputs
ranking row 2587765 |
| 198 | = | Peritoneal Carcinomatosis | 295 | 91.4 | Medium confidence | pubmed | inputs
ranking row 2587766 |
| 199 | = | Serous Cystadenocarcinoma | 292 | 91.4 | Medium confidence | pubmed | inputs
ranking row 2587767 |
| 200 | = | Malignant Mesothelioma | 289 | 91.3 | Medium confidence | pubmed | inputs
ranking row 2587768 |
| 201 | = | B Acute Lymphoblastic Leukemia | 288 | 91.3 | Medium confidence | pubmed | inputs
ranking row 2587769 |
| 202 | = | Malignant Anal Neoplasm | 284 | 91.2 | Medium confidence | pubmed | inputs
ranking row 2587770 |
| 203 | = | Marginal Zone Lymphoma | 281 | 91.2 | Medium confidence | pubmed | inputs
ranking row 2587771 |
| 204 | = | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 275 | 91.1 | Medium confidence | pubmed | inputs
ranking row 2587772 |
| 205 | = | Oral Cavity Carcinoma | 273 | 91.1 | Medium confidence | pubmed | inputs
ranking row 2587773 |
| 206 | = | Papillary Carcinoma | 269 | 91.1 | Medium confidence | pubmed | inputs
ranking row 2587774 |
| 207 | = | Adult Fibrosarcoma | 252 | 91 | Medium confidence | pubmed | inputs
ranking row 2587775 |
| 207 | = | Childhood Fibrosarcoma | 252 | 91 | Medium confidence | pubmed | inputs
ranking row 2587776 |
| 209 | = | Cervical Squamous Cell Carcinoma | 247 | 90.9 | Medium confidence | pubmed | inputs
ranking row 2587777 |
| 210 | = | Head and Neck Carcinoma | 241 | 90.9 | Medium confidence | pubmed | inputs
ranking row 2587778 |
| 211 | = | Atypical Teratoid/Rhabdoid Tumor | 240 | 90.8 | Medium confidence | pubmed | inputs
ranking row 2587779 |
| 212 | = | Adult Anaplastic Large Cell Lymphoma | 236 | 90.8 | Medium confidence | pubmed | inputs
ranking row 2587780 |
| 212 | = | Childhood Anaplastic Large Cell Lymphoma | 236 | 90.8 | Medium confidence | pubmed | inputs
ranking row 2587781 |
| 212 | = | Childhood Burkitt Lymphoma | 236 | 90.8 | Medium confidence | pubmed | inputs
ranking row 2587782 |
| 215 | = | Adult Burkitt Lymphoma | 235 | 90.7 | Medium confidence | pubmed | inputs
ranking row 2587784 |
| 215 | = | Mucinous Adenocarcinoma | 235 | 90.7 | Medium confidence | pubmed | inputs
ranking row 2587783 |
| 217 | = | Invasive Breast Lobular Carcinoma | 229 | 90.6 | Medium confidence | pubmed | inputs
ranking row 2587785 |
| 218 | = | Malignant Oral Cavity Neoplasm | 228 | 90.5 | Medium confidence | pubmed | inputs
ranking row 2587786 |
| 219 | = | Skin Squamous Cell Carcinoma | 222 | 90.5 | Medium confidence | pubmed | inputs
ranking row 2587787 |
| 220 | = | Penile Carcinoma | 220 | 90.4 | Medium confidence | pubmed | inputs
ranking row 2587788 |
| 221 | = | Malignant Uterine Neoplasm | 219 | 90.4 | Medium confidence | pubmed | inputs
ranking row 2587789 |
| 222 | = | Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements | 213 | 90.4 | Medium confidence | pubmed | inputs
ranking row 2587790 |
| 223 | = | Adult Synovial Sarcoma | 211 | 90.3 | Medium confidence | pubmed | inputs
ranking row 2587791 |
| 223 | = | Childhood Synovial Sarcoma | 211 | 90.3 | Medium confidence | pubmed | inputs
ranking row 2587792 |
| 223 | = | Malignant Penile Neoplasm | 211 | 90.3 | Medium confidence | pubmed | inputs
ranking row 2587793 |
| 223 | = | Papillary Renal Cell Carcinoma | 211 | 90.3 | Medium confidence | pubmed | inputs
ranking row 2587794 |
| 227 | = | Ewing Sarcoma | 209 | 90.1 | Medium confidence | pubmed | inputs
ranking row 2587795 |
| 228 | = | Uveal Melanoma | 207 | 90.1 | Medium confidence | pubmed | inputs
ranking row 2587796 |
| 229 | = | Adult Penile Carcinoma | 204 | 90.1 | Medium confidence | pubmed | inputs
ranking row 2587797 |
| 230 | = | Follicular Lymphoma | 203 | 90 | Medium confidence | pubmed | inputs
ranking row 2587798 |
| 230 | = | High Risk Neuroblastoma | 203 | 90 | Medium confidence | pubmed | inputs
ranking row 2587799 |
| 230 | = | Tongue Squamous Cell Carcinoma | 203 | 90 | Medium confidence | pubmed | inputs
ranking row 2587800 |
| 233 | = | Diffuse Midline Glioma | 202 | 89.9 | Medium confidence | pubmed | inputs
ranking row 2587803 |
| 233 | = | Malignant Peritoneal Neoplasm | 202 | 89.9 | Medium confidence | pubmed | inputs
ranking row 2587801 |
| 233 | = | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 202 | 89.9 | Medium confidence | pubmed | inputs
ranking row 2587802 |
| 236 | = | Lung Non-Squamous Non-Small Cell Carcinoma | 199 | 89.8 | Medium confidence | pubmed | inputs
ranking row 2587804 |
| 237 | = | Medulloblastoma, Not Otherwise Specified | 197 | 89.7 | Medium confidence | pubmed | inputs
ranking row 2587805 |
| 238 | = | Breast Carcinoma In Situ | 196 | 89.7 | Medium confidence | pubmed | inputs
ranking row 2587806 |
| 238 | = | Gastroesophageal Junction Adenocarcinoma | 196 | 89.7 | Medium confidence | pubmed | inputs
ranking row 2587807 |
| 238 | = | Vulvar Carcinoma | 196 | 89.7 | Medium confidence | pubmed | inputs
ranking row 2587808 |
| 241 | = | Medulloblastoma | 194 | 89.5 | Medium confidence | pubmed | inputs
ranking row 2587809 |
| 242 | = | Laryngeal Squamous Cell Carcinoma | 192 | 89.5 | Medium confidence | pubmed | inputs
ranking row 2587810 |
| 243 | = | Adult Classic Hodgkin Lymphoma | 189 | 89.4 | Medium confidence | pubmed | inputs
ranking row 2587813 |
| 243 | = | Intraductal Carcinoma | 189 | 89.4 | Medium confidence | pubmed | inputs
ranking row 2587811 |
| 243 | = | Signet Ring Cell Adenocarcinoma | 189 | 89.4 | Medium confidence | pubmed | inputs
ranking row 2587812 |
| 243 | = | Tongue Carcinoma | 189 | 89.4 | Medium confidence | pubmed | inputs
ranking row 2587814 |
| 247 | = | Large Duct Intrahepatic Cholangiocarcinoma | 186 | 89.3 | Medium confidence | pubmed | inputs
ranking row 2587815 |
| 248 | = | Myosarcoma | 184 | 89.2 | Medium confidence | pubmed | inputs
ranking row 2587816 |
| 248 | = | Retinoblastoma | 184 | 89.2 | Medium confidence | pubmed | inputs
ranking row 2587817 |
| 248 | = | Rhabdomyosarcoma | 184 | 89.2 | Medium confidence | pubmed | inputs
ranking row 2587818 |
| 251 | = | Malignant Vulvar Neoplasm | 181 | 89.1 | Medium confidence | pubmed | inputs
ranking row 2587819 |
| 252 | = | Testicular Choriocarcinoma | 180 | 89.1 | Medium confidence | pubmed | inputs
ranking row 2587820 |
| 253 | = | Acral Lentiginous Melanoma | 179 | 89 | Medium confidence | pubmed | inputs
ranking row 2587822 |
| 253 | = | Uterine Corpus Choriocarcinoma | 179 | 89 | Medium confidence | pubmed | inputs
ranking row 2587821 |
| 255 | = | Primary Myelofibrosis | 178 | 88.9 | Medium confidence | pubmed | inputs
ranking row 2587823 |
| 256 | = | Aggressive Non-Hodgkin Lymphoma | 173 | 88.9 | Medium confidence | pubmed | inputs
ranking row 2587824 |
| 256 | = | Pancreatic Signet Ring Cell Adenocarcinoma | 173 | 88.9 | Medium confidence | pubmed | inputs
ranking row 2587825 |
| 258 | = | Large Cell Neuroendocrine Carcinoma | 170 | 88.8 | Medium confidence | pubmed | inputs
ranking row 2587826 |
| 259 | = | Breast Adenocarcinoma | 168 | 88.7 | Medium confidence | pubmed | inputs
ranking row 2587827 |
| 260 | = | Hypopharyngeal Carcinoma | 167 | 88.7 | Medium confidence | pubmed | inputs
ranking row 2587828 |
| 261 | = | Adult Undifferentiated Pleomorphic Sarcoma | 166 | 88.7 | Medium confidence | pubmed | inputs
ranking row 2587829 |
| 261 | = | Childhood Undifferentiated Pleomorphic Sarcoma | 166 | 88.7 | Medium confidence | pubmed | inputs
ranking row 2587830 |
| 263 | = | Lung Non-Small Cell Carcinoma with EGFR Mutation | 165 | 88.6 | Medium confidence | pubmed | inputs
ranking row 2587831 |
| 264 | = | Mucosal Melanoma | 159 | 88.5 | Medium confidence | pubmed | inputs
ranking row 2587833 |
| 264 | = | Small Lymphocytic Lymphoma | 159 | 88.5 | Medium confidence | pubmed | inputs
ranking row 2587834 |
| 264 | = | Thymus Carcinoma | 159 | 88.5 | Medium confidence | pubmed | inputs
ranking row 2587832 |
| 267 | = | T Acute Lymphoblastic Leukemia | 158 | 88.4 | Medium confidence | pubmed | inputs
ranking row 2587835 |
| 268 | = | Mantle Cell Lymphoma | 156 | 88.4 | Medium confidence | pubmed | inputs
ranking row 2587836 |
| 269 | = | Adult Malignant Peripheral Nerve Sheath Tumor | 154 | 88.3 | Medium confidence | pubmed | inputs
ranking row 2587837 |
| 269 | = | Carcinoma of Unknown Primary | 154 | 88.3 | Medium confidence | pubmed | inputs
ranking row 2587838 |
| 269 | = | Malignant Nasopharyngeal Neoplasm | 154 | 88.3 | Medium confidence | pubmed | inputs
ranking row 2587839 |
| 272 | = | Malignant Intestinal Neoplasm | 153 | 88.2 | Medium confidence | pubmed | inputs
ranking row 2587840 |
| 273 | = | Dedifferentiated Liposarcoma | 150 | 88.1 | Medium confidence | pubmed | inputs
ranking row 2587842 |
| 273 | = | Endometrioid Adenocarcinoma | 150 | 88.1 | Medium confidence | pubmed | inputs
ranking row 2587841 |
| 275 | = | Male Breast Carcinoma | 149 | 88.1 | Medium confidence | pubmed | inputs
ranking row 2587843 |
| 276 | = | Bone Sarcoma | 148 | 88 | Medium confidence | pubmed | inputs
ranking row 2587844 |
| 277 | = | Malignant Tongue Neoplasm | 147 | 88 | Medium confidence | pubmed | inputs
ranking row 2587845 |
| 278 | = | Adult Lymphoblastic Lymphoma | 146 | 87.9 | Medium confidence | pubmed | inputs
ranking row 2587847 |
| 278 | = | Childhood Lymphoblastic Lymphoma | 146 | 87.9 | Medium confidence | pubmed | inputs
ranking row 2587848 |
| 278 | = | Lymphoblastic Lymphoma | 146 | 87.9 | Medium confidence | pubmed | inputs
ranking row 2587846 |
| 281 | = | Pulmonary Artery Intimal Sarcoma | 142 | 87.8 | Medium confidence | pubmed | inputs
ranking row 2587849 |
| 282 | = | Thyroid Gland Anaplastic Carcinoma | 141 | 87.7 | Medium confidence | pubmed | inputs
ranking row 2587850 |
| 283 | = | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 137 | 87.7 | Medium confidence | pubmed | inputs
ranking row 2587851 |
| 283 | = | Undifferentiated Carcinoma | 137 | 87.7 | Medium confidence | pubmed | inputs
ranking row 2587852 |
| 285 | = | ALK-Positive Lung Non-Small Cell Carcinoma | 136 | 87.6 | Medium confidence | pubmed | inputs
ranking row 2587853 |
| 285 | = | Thyroid Gland Papillary Microcarcinoma | 136 | 87.6 | Medium confidence | pubmed | inputs
ranking row 2587854 |
| 287 | = | Angiosarcoma | 134 | 87.5 | Medium confidence | pubmed | inputs
ranking row 2587855 |
| 287 | = | Extrahepatic Cholangiocarcinoma | 134 | 87.5 | Medium confidence | pubmed | inputs
ranking row 2587858 |
| 287 | = | Kaposi Sarcoma | 134 | 87.5 | Medium confidence | pubmed | inputs
ranking row 2587856 |
| 287 | = | Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion | 134 | 87.5 | Medium confidence | pubmed | inputs
ranking row 2587857 |
| 291 | = | Poorly Differentiated Thyroid Gland Carcinoma | 133 | 87.4 | Medium confidence | pubmed | inputs
ranking row 2587859 |
| 292 | = | Bladder Urothelial Carcinoma | 132 | 87.3 | Medium confidence | pubmed | inputs
ranking row 2587860 |
| 292 | = | Malignant Hypopharyngeal Neoplasm | 132 | 87.3 | Medium confidence | pubmed | inputs
ranking row 2587861 |
| 294 | = | Liposarcoma | 131 | 87.2 | Medium confidence | pubmed | inputs
ranking row 2587862 |
| 295 | = | Ovarian Mucinous Adenocarcinoma | 128 | 87.2 | Medium confidence | pubmed | inputs
ranking row 2587863 |
| 296 | = | Acral Melanoma | 126 | 87.1 | Medium confidence | pubmed | inputs
ranking row 2587864 |
| 296 | = | Mycosis Fungoides | 126 | 87.1 | Medium confidence | pubmed | inputs
ranking row 2587865 |
| 298 | = | Adrenal Cortical Carcinoma | 125 | 87 | Medium confidence | pubmed | inputs
ranking row 2587866 |
| 298 | = | Cervical Adenosquamous Carcinoma | 125 | 87 | Medium confidence | pubmed | inputs
ranking row 2587867 |
| 300 | = | Pancreatic Adenosquamous Carcinoma | 124 | 87 | Medium confidence | pubmed | inputs
ranking row 2587869 |
| 300 | = | Sarcomatoid Carcinoma | 124 | 87 | Medium confidence | pubmed | inputs
ranking row 2587868 |
| 302 | = | Chromophobe Renal Cell Carcinoma | 123 | 86.9 | Medium confidence | pubmed | inputs
ranking row 2587871 |
| 302 | = | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | 123 | 86.9 | Medium confidence | pubmed | inputs
ranking row 2587870 |
| 304 | = | Choroid Melanoma | 120 | 86.8 | Medium confidence | pubmed | inputs
ranking row 2587874 |
| 304 | = | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 120 | 86.8 | Medium confidence | pubmed | inputs
ranking row 2587875 |
| 304 | = | Fibrosarcoma | 120 | 86.8 | Medium confidence | pubmed | inputs
ranking row 2587872 |
| 304 | = | Pleural Malignant Mesothelioma | 120 | 86.8 | Medium confidence | pubmed | inputs
ranking row 2587873 |
| 308 | = | Adenoid Cystic Carcinoma | 118 | 86.6 | Medium confidence | pubmed | inputs
ranking row 2587876 |
| 308 | = | Leiomyosarcoma | 118 | 86.6 | Medium confidence | pubmed | inputs
ranking row 2587877 |
| 308 | = | Pelvic Soft Tissue Sarcoma | 118 | 86.6 | Medium confidence | pubmed | inputs
ranking row 2587878 |
| 311 | = | Platinum-Resistant Ovarian Carcinoma | 116 | 86.5 | Medium confidence | pubmed | inputs
ranking row 2587880 |
| 311 | = | Wilms Tumor | 116 | 86.5 | Medium confidence | pubmed | inputs
ranking row 2587879 |
| 313 | = | Thyroid Gland Follicular Carcinoma | 114 | 86.4 | Medium confidence | pubmed | inputs
ranking row 2587881 |
| 314 | = | Distal Cholangiocarcinoma | 113 | 86.3 | Medium confidence | pubmed | inputs
ranking row 2587882 |
| 315 | = | Pancreatic Undifferentiated Carcinoma | 111 | 86.3 | Medium confidence | pubmed | inputs
ranking row 2587883 |
| 316 | = | Melanoma In Situ | 110 | 86.3 | Medium confidence | pubmed | inputs
ranking row 2587884 |
| 317 | = | Penile Squamous Cell Carcinoma | 109 | 86.2 | Medium confidence | pubmed | inputs
ranking row 2587885 |
| 317 | = | Retroperitoneal Sarcoma | 109 | 86.2 | Medium confidence | pubmed | inputs
ranking row 2587886 |
| 319 | = | Chondrosarcoma | 108 | 86.1 | Medium confidence | pubmed | inputs
ranking row 2587887 |
| 319 | = | High Grade B-Cell Lymphoma | 108 | 86.1 | Medium confidence | pubmed | inputs
ranking row 2587888 |
| 321 | = | Breast Lobular Carcinoma | 107 | 86 | Medium confidence | pubmed | inputs
ranking row 2587889 |
| 322 | = | Cervical Adenocarcinoma | 106 | 86 | Medium confidence | pubmed | inputs
ranking row 2587890 |
| 322 | = | Polycythemia Vera | 106 | 86 | Medium confidence | pubmed | inputs
ranking row 2587891 |
| 324 | = | Solid Pseudopapillary Neoplasm | 104 | 85.9 | Medium confidence | pubmed | inputs
ranking row 2587892 |
| 325 | = | Lymphoplasmacytic Lymphoma | 103 | 85.9 | Medium confidence | pubmed | inputs
ranking row 2587894 |
| 325 | = | Merkel Cell Carcinoma | 103 | 85.9 | Medium confidence | pubmed | inputs
ranking row 2587893 |
| 327 | = | Hilar Cholangiocarcinoma | 102 | 85.8 | Medium confidence | pubmed | inputs
ranking row 2587895 |
| 327 | = | Xanthogranuloma | 102 | 85.8 | Medium confidence | pubmed | inputs
ranking row 2587896 |
| 329 | = | Cutaneous Lymphoma | 101 | 85.7 | Medium confidence | pubmed | inputs
ranking row 2587897 |
| 330 | = | Hypopharyngeal Squamous Cell Carcinoma | 100 | 85.7 | Medium confidence | pubmed | inputs
ranking row 2587899 |
| 330 | = | Stromal Sarcoma | 100 | 85.7 | Medium confidence | pubmed | inputs
ranking row 2587898 |
| 332 | = | Clear Cell Adenocarcinoma | 99 | 85.6 | Medium confidence | pubmed | inputs
ranking row 2587900 |
| 333 | = | Primary Cutaneous Lymphoma | 98 | 85.5 | Medium confidence | pubmed | inputs
ranking row 2587902 |
| 333 | = | Secondary Acute Myeloid Leukemia | 98 | 85.5 | Medium confidence | pubmed | inputs
ranking row 2587901 |
| 333 | = | Well-Differentiated Liposarcoma | 98 | 85.5 | Medium confidence | pubmed | inputs
ranking row 2587903 |
| 336 | = | Adult Yolk Sac Tumor | 97 | 85.4 | Medium confidence | pubmed | inputs
ranking row 2587904 |
| 336 | = | Ovarian Yolk Sac Tumor | 97 | 85.4 | Medium confidence | pubmed | inputs
ranking row 2587906 |
| 336 | = | Testicular Yolk Sac Tumor | 97 | 85.4 | Medium confidence | pubmed | inputs
ranking row 2587907 |
| 336 | = | Vaginal Yolk Sac Tumor | 97 | 85.4 | Medium confidence | pubmed | inputs
ranking row 2587905 |
| 340 | = | Childhood Renal Cell Carcinoma | 96 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2587910 |
| 340 | = | Chordoma | 96 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2587908 |
| 340 | = | Early Stage Hepatocellular Carcinoma | 96 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2587911 |
| 340 | = | Nasal Type Extranodal NK/T-Cell Lymphoma | 96 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2587912 |
| 340 | = | Plasmacytoid Dendritic Cell Neoplasm | 96 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2587909 |
| 345 | = | Malignant Neoplasm of Unknown Primary | 95 | 85 | Medium confidence | pubmed | inputs
ranking row 2587913 |
| 346 | = | Hepatoblastoma | 94 | 85 | Medium confidence | pubmed | inputs
ranking row 2587914 |
| 346 | = | Poorly Differentiated Adenocarcinoma | 94 | 85 | Medium confidence | pubmed | inputs
ranking row 2587915 |
| 348 | = | Intrathyroid Thymic Carcinoma | 92 | 84.9 | Medium confidence | pubmed | inputs
ranking row 2587916 |
| 349 | = | Extraosseous Plasmacytoma | 91 | 84.8 | Medium confidence | pubmed | inputs
ranking row 2587917 |
| 349 | = | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 91 | 84.8 | Medium confidence | pubmed | inputs
ranking row 2587918 |
| 351 | = | Invasive Cervical Carcinoma | 90 | 84.7 | Medium confidence | pubmed | inputs
ranking row 2587920 |
| 351 | = | Invasive Urothelial Carcinoma | 90 | 84.7 | Medium confidence | pubmed | inputs
ranking row 2587921 |
| 351 | = | Malignant Salivary Gland Neoplasm | 90 | 84.7 | Medium confidence | pubmed | inputs
ranking row 2587919 |
| 354 | = | Mixed Phenotype Acute Leukemia | 89 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2587922 |
| 355 | = | Anal Squamous Cell Carcinoma | 88 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2587923 |
| 355 | = | HER2-Low Breast Carcinoma | 88 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2587925 |
| 355 | = | Uterine Corpus Sarcoma | 88 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2587924 |
| 358 | = | Childhood Leukemia | 87 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2587926 |
| 358 | = | Extranodal Lymphoma | 87 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2587927 |
| 358 | = | Glioblastoma, IDH-Wildtype | 87 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2587928 |
| 358 | = | Parathyroid Carcinoma | 87 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2587930 |
| 358 | = | Parathyroid Gland Carcinoma | 87 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2587929 |
| 363 | = | Acute Promyelocytic Leukemia | 86 | 84.2 | Medium confidence | pubmed | inputs
ranking row 2587932 |
| 363 | = | Appendix Mucinous Neoplasm | 86 | 84.2 | Medium confidence | pubmed | inputs
ranking row 2587931 |
| 365 | = | Adult Hepatocellular Carcinoma | 85 | 84.1 | Medium confidence | pubmed | inputs
ranking row 2587934 |
| 365 | = | Breast Metaplastic Carcinoma | 85 | 84.1 | Medium confidence | pubmed | inputs
ranking row 2587933 |
| 365 | = | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 85 | 84.1 | Medium confidence | pubmed | inputs
ranking row 2587935 |
| 368 | = | Endocervical Adenocarcinoma | 84 | 84 | Medium confidence | pubmed | inputs
ranking row 2587937 |
| 368 | = | Malignant Bile Duct Neoplasm | 84 | 84 | Medium confidence | pubmed | inputs
ranking row 2587936 |
| 370 | = | Childhood Hepatocellular Carcinoma | 83 | 83.9 | Medium confidence | pubmed | inputs
ranking row 2587938 |
| 370 | = | Indolent Non-Hodgkin Lymphoma | 83 | 83.9 | Medium confidence | pubmed | inputs
ranking row 2587939 |
| 370 | = | Uterine Corpus Leiomyosarcoma | 83 | 83.9 | Medium confidence | pubmed | inputs
ranking row 2587940 |
| 373 | = | Hereditary Breast Carcinoma | 82 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2587941 |
| 373 | = | NUT Carcinoma | 82 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2587942 |
| 373 | = | Primary Mediastinal Large B-Cell Lymphoma | 82 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2587943 |
| 373 | = | Urothelial Carcinoma, High Grade | 82 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2587944 |
| 373 | = | Waldenstrom Macroglobulinemia | 82 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2587945 |
| 378 | = | Adult T-Cell Leukemia/Lymphoma | 81 | 83.6 | Medium confidence | pubmed | inputs
ranking row 2587947 |
| 378 | = | Myelodysplastic/Myeloproliferative Neoplasm | 81 | 83.6 | Medium confidence | pubmed | inputs
ranking row 2587946 |
| 378 | = | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 81 | 83.6 | Medium confidence | pubmed | inputs
ranking row 2587948 |
| 381 | = | Germinoma | 78 | 83.4 | Medium confidence | pubmed | inputs
ranking row 2587950 |
| 381 | = | Lymphoepithelial Carcinoma | 78 | 83.4 | Medium confidence | pubmed | inputs
ranking row 2587949 |
| 381 | = | Vaginal Carcinoma | 78 | 83.4 | Medium confidence | pubmed | inputs
ranking row 2587951 |
| 384 | = | Low Grade Appendix Mucinous Neoplasm | 77 | 83.3 | Medium confidence | pubmed | inputs
ranking row 2587952 |
| 385 | = | Endometrial Adenocarcinoma | 76 | 83.3 | Medium confidence | pubmed | inputs
ranking row 2587954 |
| 385 | = | Moderately Differentiated Adenocarcinoma | 76 | 83.3 | Medium confidence | pubmed | inputs
ranking row 2587953 |
| 387 | = | Adult B Acute Lymphoblastic Leukemia | 75 | 83.2 | Medium confidence | pubmed | inputs
ranking row 2587955 |
| 388 | = | Myxofibrosarcoma | 74 | 83.1 | Medium confidence | pubmed | inputs
ranking row 2587956 |
| 389 | = | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 73 | 83.1 | Medium confidence | pubmed | inputs
ranking row 2587957 |
| 389 | = | Intravascular Large B-Cell Lymphoma | 73 | 83.1 | Medium confidence | pubmed | inputs
ranking row 2587958 |
| 391 | = | Burkitt Lymphoma | 72 | 83 | Medium confidence | pubmed | inputs
ranking row 2587961 |
| 391 | = | Invasive Cutaneous Melanoma | 72 | 83 | Medium confidence | pubmed | inputs
ranking row 2587959 |
| 391 | = | Vulvar Squamous Cell Carcinoma | 72 | 83 | Medium confidence | pubmed | inputs
ranking row 2587960 |
| 394 | = | Acute Monocytic Leukemia | 70 | 82.9 | Medium confidence | pubmed | inputs
ranking row 2587964 |
| 394 | = | Ampulla of Vater Carcinoma | 70 | 82.9 | Medium confidence | pubmed | inputs
ranking row 2587963 |
| 394 | = | Combined Hepatocellular Carcinoma and Cholangiocarcinoma | 70 | 82.9 | Medium confidence | pubmed | inputs
ranking row 2587962 |
| 397 | = | Serous Tubal Intraepithelial Carcinoma | 69 | 82.7 | Medium confidence | pubmed | inputs
ranking row 2587965 |
| 398 | = | Breast Implant-Associated Anaplastic Large Cell Lymphoma | 68 | 82.7 | Medium confidence | pubmed | inputs
ranking row 2587966 |
| 399 | = | Adult Epithelioid Hemangioendothelioma | 67 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2587968 |
| 399 | = | Childhood Embryonal Rhabdomyosarcoma | 67 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2587970 |
| 399 | = | Childhood Epithelioid Hemangioendothelioma | 67 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2587967 |
| 399 | = | Malignant Vaginal Neoplasm | 67 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2587969 |
| 403 | = | Essential Thrombocythemia | 65 | 82.5 | Medium confidence | pubmed | inputs
ranking row 2587972 |
| 403 | = | Malignant Genitourinary System Neoplasm | 65 | 82.5 | Medium confidence | pubmed | inputs
ranking row 2587971 |
| 403 | = | Neck Carcinoma | 65 | 82.5 | Medium confidence | pubmed | inputs
ranking row 2587973 |
| 406 | = | Pancreatic Medullary Carcinoma | 64 | 82.3 | Medium confidence | pubmed | inputs
ranking row 2587976 |
| 406 | = | Salivary Gland Carcinoma | 64 | 82.3 | Medium confidence | pubmed | inputs
ranking row 2587974 |
| 406 | = | Small Cell Neuroendocrine Carcinoma | 64 | 82.3 | Medium confidence | pubmed | inputs
ranking row 2587975 |
| 409 | = | Acute Undifferentiated Leukemia | 63 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2587977 |
| 410 | = | Anaplastic Large Cell Lymphoma | 62 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2587978 |
| 410 | = | Low-grade Appendiceal Mucinous Neoplasm | 62 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2587979 |
| 412 | = | Childhood Atypical Teratoid/Rhabdoid Tumor | 61 | 82.1 | Medium confidence | pubmed | inputs
ranking row 2587981 |
| 412 | = | Malignant Central Nervous System Neoplasm | 61 | 82.1 | Medium confidence | pubmed | inputs
ranking row 2587980 |
| 414 | = | Anaplastic Astrocytoma | 60 | 82 | Medium confidence | pubmed | inputs
ranking row 2587982 |
| 414 | = | Childhood B Acute Lymphoblastic Leukemia | 60 | 82 | Medium confidence | pubmed | inputs
ranking row 2587983 |
| 414 | = | Salivary Duct Carcinoma | 60 | 82 | Medium confidence | pubmed | inputs
ranking row 2587984 |
| 417 | = | Spindle Cell Sarcoma | 59 | 81.9 | Medium confidence | pubmed | inputs
ranking row 2587985 |
| 418 | = | Apocrine Carcinoma | 58 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2587989 |
| 418 | = | Appendix Adenocarcinoma | 58 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2587990 |
| 418 | = | Intimal Sarcoma | 58 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2587987 |
| 418 | = | Malignant Myoepithelioma | 58 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2587986 |
| 418 | = | Seminoma | 58 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2587988 |
| 423 | = | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 57 | 81.6 | Medium confidence | pubmed | inputs
ranking row 2587991 |
| 423 | = | Pleural Mesothelioma In Situ | 57 | 81.6 | Medium confidence | pubmed | inputs
ranking row 2587992 |
| 425 | = | Chronic Myelomonocytic Leukemia | 56 | 81.5 | Medium confidence | pubmed | inputs
ranking row 2587993 |
| 425 | = | Undifferentiated Sarcoma | 56 | 81.5 | Medium confidence | pubmed | inputs
ranking row 2587994 |
| 427 | = | Adult Epithelioid Sarcoma | 55 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2587999 |
| 427 | = | Childhood Epithelioid Sarcoma | 55 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2588000 |
| 427 | = | Epithelioid Sarcoma | 55 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2587997 |
| 427 | = | HER2-Positive Gastric Adenocarcinoma | 55 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2588001 |
| 427 | = | Malignant Appendix Neoplasm | 55 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2587995 |
| 427 | = | Malignant Neoplasm of Lung - Multiple Primary Sites | 55 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2587996 |
| 427 | = | Mucoepidermoid Carcinoma | 55 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2587998 |
| 434 | = | Central Nervous System Embryonal Carcinoma | 54 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2588003 |
| 434 | = | Grade 3a Follicular Lymphoma | 54 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2588007 |
| 434 | = | Meningeal Carcinomatosis | 54 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2588006 |
| 434 | = | Ocular Melanoma | 54 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2588002 |
| 434 | = | Ovarian Embryonal Carcinoma | 54 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2588004 |
| 434 | = | Testicular Embryonal Carcinoma | 54 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2588005 |
| 440 | = | Salivary Gland Myoepithelial Carcinoma | 53 | 80.9 | Medium confidence | pubmed | inputs
ranking row 2588008 |
| 440 | = | Small Intestinal Adenocarcinoma | 53 | 80.9 | Medium confidence | pubmed | inputs
ranking row 2588010 |
| 440 | = | Synovial Sarcoma | 53 | 80.9 | Medium confidence | pubmed | inputs
ranking row 2588009 |
| 443 | = | Childhood Acute Leukemia | 52 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2588013 |
| 443 | = | Extraskeletal Ewing Sarcoma | 52 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2588014 |
| 443 | = | Malignant Pelvic Neoplasm | 52 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2588011 |
| 443 | = | Molar Pregnancy | 52 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2588016 |
| 443 | = | Pharyngeal Carcinoma | 52 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2588015 |
| 443 | = | Rare Childhood Malignant Neoplasm | 52 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2588012 |
| 449 | = | Castration-Sensitive Prostate Carcinoma | 51 | 80.5 | Medium confidence | pubmed | inputs
ranking row 2588018 |
| 449 | = | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 51 | 80.5 | Medium confidence | pubmed | inputs
ranking row 2588017 |
| 449 | = | Low-Grade Serous Ovarian Cancer | 51 | 80.5 | Medium confidence | pubmed | inputs
ranking row 2588020 |
| 449 | = | Lung Small Cell Carcinoma, A Subtype | 51 | 80.5 | Medium confidence | pubmed | inputs
ranking row 2588019 |
| 453 | = | Brain Embryonal Tumor, Not Otherwise Specified | 50 | 80.3 | Medium confidence | pubmed | inputs
ranking row 2588022 |
| 453 | = | Breast Periductal Stromal Tumor | 50 | 80.3 | Medium confidence | pubmed | inputs
ranking row 2588021 |
| 453 | = | Childhood Alveolar Rhabdomyosarcoma | 50 | 80.3 | Medium confidence | pubmed | inputs
ranking row 2588024 |
| 453 | = | Gastric Papillary Adenocarcinoma | 50 | 80.3 | Medium confidence | pubmed | inputs
ranking row 2588023 |
| 453 | = | Ovarian Low Grade Serous Adenocarcinoma | 50 | 80.3 | Medium confidence | pubmed | inputs
ranking row 2588025 |
| 458 | = | Malignant Thoracic Neoplasm | 49 | 80.1 | Medium confidence | pubmed | inputs
ranking row 2588026 |
| 458 | = | Parotid Gland Carcinoma | 49 | 80.1 | Medium confidence | pubmed | inputs
ranking row 2588027 |
| 460 | = | Breast Lobular Carcinoma In Situ | 48 | 80 | Medium confidence | pubmed | inputs
ranking row 2588029 |
| 460 | = | Carcinosarcoma | 48 | 80 | Medium confidence | pubmed | inputs
ranking row 2588030 |
| 460 | = | Malignant Nervous System Neoplasm | 48 | 80 | Medium confidence | pubmed | inputs
ranking row 2588028 |
| 460 | = | Metaplastic Carcinoma | 48 | 80 | Medium confidence | pubmed | inputs
ranking row 2588031 |
| 460 | = | MSI-H Colorectal Carcinoma | 48 | 80 | Medium confidence | pubmed | inputs
ranking row 2588034 |
| 460 | = | Pineal Region Germinoma | 48 | 80 | Medium confidence | pubmed | inputs
ranking row 2588033 |
| 460 | = | Prostate Intraductal Carcinoma | 48 | 80 | Medium confidence | pubmed | inputs
ranking row 2588032 |
| 467 | = | Fibrolamellar Carcinoma | 47 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2588038 |
| 467 | = | Keratoacanthoma | 47 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2588037 |
| 467 | = | Large Cell Carcinoma | 47 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2588036 |
| 467 | = | Malignant Abdominal Neoplasm | 47 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2588035 |
| 467 | = | Non-Clear Cell Renal Cell Carcinoma | 47 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2588040 |
| 467 | = | Skin Keratoacanthoma | 47 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2588039 |
| 473 | = | Breast Secretory Carcinoma | 46 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2588042 |
| 473 | = | Choriocarcinoma | 46 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2588041 |
| 473 | = | Small Hepatocellular Carcinoma | 46 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2588043 |
| 476 | = | Acute Myeloid Leukemia Post Cytotoxic Therapy | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588045 |
| 476 | = | B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588053 |
| 476 | = | Endometrial Serous Adenocarcinoma | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588050 |
| 476 | = | Hepatoid Adenocarcinoma | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588046 |
| 476 | = | Malignant Pharyngeal Neoplasm | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588047 |
| 476 | = | Ovarian Adenocarcinoma | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588051 |
| 476 | = | Sezary Syndrome | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588052 |
| 476 | = | Sinonasal Carcinoma | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588048 |
| 476 | = | Solitary Plasmacytoma | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588049 |
| 476 | = | Well Differentiated Adenocarcinoma | 45 | 79.3 | Medium confidence | pubmed | inputs
ranking row 2588044 |
| 486 | = | Complete Hydatidiform Mole | 44 | 78.8 | Medium confidence | pubmed | inputs
ranking row 2588056 |
| 486 | = | Early Hepatocellular Carcinoma | 44 | 78.8 | Medium confidence | pubmed | inputs
ranking row 2588054 |
| 486 | = | Periampullary Adenocarcinoma | 44 | 78.8 | Medium confidence | pubmed | inputs
ranking row 2588055 |
| 489 | = | Childhood Sarcoma | 43 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2588057 |
| 489 | = | Leukemia Cutis | 43 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2588058 |
| 489 | = | Lung Large Cell Carcinoma | 43 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2588059 |
| 492 | = | Adult Alveolar Soft Part Sarcoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588064 |
| 492 | = | Adult T Lymphoblastic Lymphoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588065 |
| 492 | = | Adult-Type Diffuse Glioma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588073 |
| 492 | = | Aggressive Adult Non-Hodgkin Lymphoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588066 |
| 492 | = | Childhood Alveolar Soft Part Sarcoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588067 |
| 492 | = | Childhood T Lymphoblastic Lymphoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588062 |
| 492 | = | Conjunctival Melanoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588060 |
| 492 | = | Gallbladder Adenocarcinoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588070 |
| 492 | = | Nodular Sclerosis Classic Hodgkin Lymphoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588068 |
| 492 | = | Peritoneal Malignant Mesothelioma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588061 |
| 492 | = | Sinonasal Non-Keratinizing Squamous Cell Carcinoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588071 |
| 492 | = | Sinonasal Squamous Cell Carcinoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588069 |
| 492 | = | TFE3-Rearranged Renal Cell Carcinoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588072 |
| 492 | = | T Lymphoblastic Lymphoma | 42 | 78.6 | Medium confidence | pubmed | inputs
ranking row 2588063 |
| 506 | = | Adenosquamous Carcinoma | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588078 |
| 506 | = | Breast Lymphoma | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588075 |
| 506 | = | EBV-Related Gastric Carcinoma | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588079 |
| 506 | = | Lung Intravascular Large B-Cell Lymphoma | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588080 |
| 506 | = | Lymphoid Neoplasm | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588082 |
| 506 | = | Malignant Endocrine Neoplasm | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588074 |
| 506 | = | Nodular Melanoma | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588076 |
| 506 | = | Nonmetastatic Castration-Resistant Prostate Carcinoma | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588081 |
| 506 | = | Solid Pseudopapillary Neoplasm of the Pancreas | 41 | 78 | Medium confidence | pubmed | inputs
ranking row 2588077 |
| 515 | = | Cardiac Angiosarcoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588089 |
| 515 | = | Cardiac Lymphoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588085 |
| 515 | = | Invasive Lung Mucinous Adenocarcinoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588086 |
| 515 | = | Low-CSD Melanoma, Superficial Spreading Melanoma Subtype | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588092 |
| 515 | = | Papillary Urothelial Carcinoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588087 |
| 515 | = | Plasmacytoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588083 |
| 515 | = | Pleuropulmonary Blastoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588084 |
| 515 | = | Primary Vitreoretinal Non-Hodgkin Lymphoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588090 |
| 515 | = | Retroperitoneal Liposarcoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588088 |
| 515 | = | Urethral Carcinoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588093 |
| 515 | = | Uterine Carcinosarcoma | 40 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2588091 |
| 526 | = | Acinar Cell Carcinoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588098 |
| 526 | = | Breast Angiosarcoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588099 |
| 526 | = | Carcinoma ex Pleomorphic Adenoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588094 |
| 526 | = | Childhood Lymphoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588095 |
| 526 | = | Keratinizing Squamous Cell Carcinoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588100 |
| 526 | = | Lung Keratinizing Squamous Cell Carcinoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588101 |
| 526 | = | Lung Lymphoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588096 |
| 526 | = | Malignant Hepatobiliary Neoplasm | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588097 |
| 526 | = | Mesonephric-Like Adenocarcinoma | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588102 |
| 526 | = | Mycosis Fungoides and Sezary Syndrome | 39 | 77.1 | Medium confidence | pubmed | inputs
ranking row 2588103 |
| 536 | = | Diffuse Intrinsic Pontine Glioma | 38 | 76.7 | Medium confidence | pubmed | inputs
ranking row 2588107 |
| 536 | = | dMMR Colorectal Carcinoma | 38 | 76.7 | Medium confidence | pubmed | inputs
ranking row 2588109 |
| 536 | = | Extramammary Paget Disease | 38 | 76.7 | Medium confidence | pubmed | inputs
ranking row 2588108 |
| 536 | = | Intestinal Lymphoma | 38 | 76.7 | Medium confidence | pubmed | inputs
ranking row 2588105 |
| 536 | = | Kidney Sarcoma | 38 | 76.7 | Medium confidence | pubmed | inputs
ranking row 2588106 |
| 536 | = | Malignant Sinonasal Neoplasm | 38 | 76.7 | Medium confidence | pubmed | inputs
ranking row 2588104 |
| 542 | = | Adult Acute Monocytic Leukemia | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588122 |
| 542 | = | Adult Desmoplastic Small Round Cell Tumor | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588118 |
| 542 | = | Childhood Acute Monocytic Leukemia | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588123 |
| 542 | = | Childhood Desmoplastic Small Round Cell Tumor | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588119 |
| 542 | = | Childhood Malignant Glioma | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588120 |
| 542 | = | Digestive System Lymphoma | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588112 |
| 542 | = | Low Grade Endometrioid Stromal Sarcoma | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588117 |
| 542 | = | Lung Large Cell Neuroendocrine Carcinoma | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588121 |
| 542 | = | Malignant Phyllodes Tumor | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588113 |
| 542 | = | Malignant Vascular Neoplasm | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588114 |
| 542 | = | Mixed Germ Cell Tumor | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588110 |
| 542 | = | Obesity-Related Malignant Neoplasm | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588111 |
| 542 | = | Ovarian Mixed Germ Cell Tumor | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588115 |
| 542 | = | Testicular Mixed Germ Cell Tumor | 37 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2588116 |
| 556 | = | Acute Leukemia of Ambiguous Lineage | 36 | 75.8 | Medium confidence | pubmed | inputs
ranking row 2588124 |
| 556 | = | Aggressive B-Cell Non-Hodgkin Lymphoma | 36 | 75.8 | Medium confidence | pubmed | inputs
ranking row 2588125 |
| 556 | = | Oncocytic Adenocarcinoma | 36 | 75.8 | Medium confidence | pubmed | inputs
ranking row 2588126 |
| 559 | = | Adamantinoma-Like Ewing Sarcoma | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588127 |
| 559 | = | Anaplastic Large Cell Lymphoma, ALK-Positive | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588128 |
| 559 | = | Childhood Ganglioneuroblastoma | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588131 |
| 559 | = | Duodenal Adenocarcinoma | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588133 |
| 559 | = | Extranodal Non-Hodgkin Lymphoma | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588129 |
| 559 | = | Glottis Carcinoma | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588134 |
| 559 | = | Intraductal Papillary Neoplasm of the Bile Duct | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588135 |
| 559 | = | Skin Angiosarcoma | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588132 |
| 559 | = | Testicular Seminoma | 35 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2588130 |
| 568 | = | Adult Gliosarcoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588140 |
| 568 | = | Atypical Lipomatous Tumor | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588147 |
| 568 | = | Childhood Gliosarcoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588141 |
| 568 | = | Gastric Tubular Adenocarcinoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588142 |
| 568 | = | Goblet Cell Adenocarcinoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588143 |
| 568 | = | Intestinal T-Cell Lymphoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588145 |
| 568 | = | Lentigo Maligna Melanoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588146 |
| 568 | = | Myeloid Sarcoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588136 |
| 568 | = | Non-Small Cell Carcinoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588137 |
| 568 | = | Orbital Lymphoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588138 |
| 568 | = | Splenic Marginal Zone Lymphoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588144 |
| 568 | = | Tubular Adenocarcinoma | 34 | 75.3 | Medium confidence | pubmed | inputs
ranking row 2588139 |
| 580 | = | Endometrial Endometrioid Adenocarcinoma | 33 | 74.7 | Medium confidence | pubmed | inputs
ranking row 2588149 |
| 580 | = | Fumarate Hydratase-Deficient Renal Cell Carcinoma | 33 | 74.7 | Medium confidence | pubmed | inputs
ranking row 2588151 |
| 580 | = | Hepatitis B Virus-Related Hepatocellular Carcinoma | 33 | 74.7 | Medium confidence | pubmed | inputs
ranking row 2588150 |
| 580 | = | Occupational Malignant Neoplasm | 33 | 74.7 | Medium confidence | pubmed | inputs
ranking row 2588148 |
| 584 | = | Acute Myeloid Leukemia, Myelodysplasia-Related | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588156 |
| 584 | = | Basal-Like Breast Carcinoma | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588159 |
| 584 | = | Blastic Plasmacytoid Dendritic Cell Neoplasm | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588154 |
| 584 | = | Cardiac Sarcoma | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588155 |
| 584 | = | CRTC1-TRIM11 Cutaneous Tumor | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588152 |
| 584 | = | Pancreatic Acinar Cell Carcinoma | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588157 |
| 584 | = | Pseudomyxoma Peritonei | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588158 |
| 584 | = | Thoracic SMARCA4-Deficient Undifferentiated Tumor | 32 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2588153 |
| 592 | = | Adult Acute Megakaryoblastic Leukemia | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588166 |
| 592 | = | Ampulla of Vater Adenocarcinoma | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588173 |
| 592 | = | Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588167 |
| 592 | = | Bowen Disease of the Skin | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588174 |
| 592 | = | Breast Inflammatory Carcinoma | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588168 |
| 592 | = | Childhood Acute Megakaryoblastic Leukemia | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588169 |
| 592 | = | Childhood Malignant Solid Neoplasm | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588162 |
| 592 | = | Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588175 |
| 592 | = | Early T Precursor Acute Lymphoblastic Leukemia | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588170 |
| 592 | = | High Grade Osteosarcoma | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588163 |
| 592 | = | Liver Angiosarcoma | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588171 |
| 592 | = | Malignant Fallopian Tube Neoplasm | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588164 |
| 592 | = | Malignant Soft Tissue Neoplasm | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588160 |
| 592 | = | Medulloblastoma, WNT-Activated | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588172 |
| 592 | = | Radiation-Related Malignant Neoplasm | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588161 |
| 592 | = | Smoldering Multiple Myeloma | 31 | 74.2 | Medium confidence | pubmed | inputs
ranking row 2588165 |
| 608 | = | Anaplastic Large Cell Lymphoma, ALK-Negative | 30 | 73.5 | Medium confidence | pubmed | inputs
ranking row 2588177 |
| 608 | = | Gestational Choriocarcinoma | 30 | 73.5 | Medium confidence | pubmed | inputs
ranking row 2588178 |
| 608 | = | Grade 3b Follicular Lymphoma | 30 | 73.5 | Medium confidence | pubmed | inputs
ranking row 2588182 |
| 608 | = | Hormone Receptor-Positive Breast Carcinoma | 30 | 73.5 | Medium confidence | pubmed | inputs
ranking row 2588179 |
| 608 | = | Ovarian Endometrioid Adenocarcinoma | 30 | 73.5 | Medium confidence | pubmed | inputs
ranking row 2588180 |
| 608 | = | Pineoblastoma | 30 | 73.5 | Medium confidence | pubmed | inputs
ranking row 2588176 |
| 608 | = | Small Intestinal Carcinoma | 30 | 73.5 | Medium confidence | pubmed | inputs
ranking row 2588181 |
| 615 | = | Acute Biphenotypic Leukemia | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588191 |
| 615 | = | Acute Myeloid Leukemia with NPM1 Mutation | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588192 |
| 615 | = | Epithelioid Hemangioendothelioma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588187 |
| 615 | = | High Grade Sarcoma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588184 |
| 615 | = | Histiocytic Sarcoma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588185 |
| 615 | = | Malignant Eye Neoplasm | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588183 |
| 615 | = | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588193 |
| 615 | = | Nodular Lymphocyte Predominant B-Cell Lymphoma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588186 |
| 615 | = | Pleomorphic Carcinoma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588188 |
| 615 | = | Pleomorphic Dermal Sarcoma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588189 |
| 615 | = | Subcutaneous Panniculitis-Like T-Cell Lymphoma | 29 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2588190 |
| 626 | = | Epithelial-Myoepithelial Carcinoma | 28 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2588194 |
| 626 | = | Myxoinflammatory Fibroblastic Sarcoma | 28 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2588196 |
| 626 | = | Sacral Chordoma | 28 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2588199 |
| 626 | = | Sinonasal Mucosal Melanoma | 28 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2588197 |
| 626 | = | Skin Sarcoma | 28 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2588195 |
| 626 | = | Thyroid Gland Lymphoma | 28 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2588198 |
| 626 | = | Uterine Corpus High Grade Endometrial Stromal Sarcoma | 28 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2588200 |
| 633 | = | Central Nervous System Leukemia | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588201 |
| 633 | = | Desmoplastic Melanoma | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588203 |
| 633 | = | Hyalinizing Clear Cell Carcinoma | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588202 |
| 633 | = | Infantile Fibrosarcoma | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588207 |
| 633 | = | Lip Squamous Cell Carcinoma | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588208 |
| 633 | = | Liver Sarcoma | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588204 |
| 633 | = | Lung Melanoma | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588205 |
| 633 | = | Malignant Urinary Tract Neoplasm | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588206 |
| 633 | = | Subungual Melanoma | 27 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2588209 |
| 642 | = | Adult Anaplastic Astrocytoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588213 |
| 642 | = | Childhood Anaplastic Astrocytoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588214 |
| 642 | = | Core Binding Factor Acute Myeloid Leukemia | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588226 |
| 642 | = | Gastric Lymphoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588215 |
| 642 | = | Head and Neck Cutaneous Squamous Cell Carcinoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588220 |
| 642 | = | High Grade Appendix Mucinous Neoplasm | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588221 |
| 642 | = | High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588227 |
| 642 | = | Kidney Medullary Carcinoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588225 |
| 642 | = | Liver Carcinoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588210 |
| 642 | = | Lymphangitic Carcinomatosis | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588222 |
| 642 | = | Malignant Duodenal Neoplasm | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588223 |
| 642 | = | Malignant Urethral Neoplasm | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588224 |
| 642 | = | Mature B-Cell Non-Hodgkin Lymphoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588216 |
| 642 | = | Myelodysplastic Syndrome Post Cytotoxic Therapy | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588217 |
| 642 | = | Myeloid Leukemia Associated with Down Syndrome | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588211 |
| 642 | = | Plasma Cell Myeloma-Induced Bone Disease | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588218 |
| 642 | = | Renal Medullary Carcinoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588228 |
| 642 | = | Sweat Gland Carcinoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588219 |
| 642 | = | T Lymphoblastic Leukemia/Lymphoma | 26 | 72 | Medium confidence | pubmed | inputs
ranking row 2588212 |
| 661 | = | Erythroleukemia | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588233 |
| 661 | = | Fallopian Tube Carcinoma | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588234 |
| 661 | = | Gliomatosis Cerebri | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588235 |
| 661 | = | High-Grade Endometrial Stromal Sarcoma | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588237 |
| 661 | = | Melanoma of Unknown Primary | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588230 |
| 661 | = | Partial Hydatidiform Mole | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588238 |
| 661 | = | Sarcoma of the Extremity | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588229 |
| 661 | = | Splenic Angiosarcoma | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588231 |
| 661 | = | Squamous Cell Carcinoma of Unknown Primary | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588236 |
| 661 | = | T-Cell Large Granular Lymphocyte Leukemia | 25 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2588232 |
| 671 | = | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588242 |
| 671 | = | Adult Primary Cutaneous Anaplastic Large Cell Lymphoma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588249 |
| 671 | = | Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588243 |
| 671 | = | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588244 |
| 671 | = | Embryonal Rhabdomyosarcoma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588250 |
| 671 | = | Epithelioid Mesothelioma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588245 |
| 671 | = | Grade 3 Meningioma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588246 |
| 671 | = | Hereditary Gastric Diffuse Adenocarcinoma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588240 |
| 671 | = | Lung Small Cell Carcinoma, N Subtype | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588251 |
| 671 | = | Lung Small Cell Carcinoma, P Subtype | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588252 |
| 671 | = | Malignant Gastrointestinal Neuroectodermal Tumor | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588247 |
| 671 | = | Malignant Germ Cell Tumor | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588239 |
| 671 | = | Malignant Lip Neoplasm | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588248 |
| 671 | = | Micropapillary Carcinoma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588241 |
| 671 | = | Urachal Carcinoma | 24 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2588253 |
| 686 | = | Adult Erythroleukemia | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588263 |
| 686 | = | Breast Papillary Carcinoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588254 |
| 686 | = | Clear Cell Sarcoma of the Kidney | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588260 |
| 686 | = | Diffuse Large B-Cell Lymphoma Activated B-Cell Type | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588261 |
| 686 | = | Digital Papillary Adenocarcinoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588262 |
| 686 | = | Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588264 |
| 686 | = | Intestinal-Type Adenocarcinoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588257 |
| 686 | = | Low Grade Fibromyxoid Sarcoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588258 |
| 686 | = | Malignant Uterine Corpus Neoplasm | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588265 |
| 686 | = | Primary Peritoneal Carcinoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588255 |
| 686 | = | Sarcomatoid Renal Cell Carcinoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588259 |
| 686 | = | Tonsillar Squamous Cell Carcinoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588266 |
| 686 | = | Treatment-Related Prostate Neuroendocrine Carcinoma | 23 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2588256 |
| 699 | = | Clivus Chordoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588273 |
| 699 | = | Early Stage Endometrial Carcinoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588274 |
| 699 | = | Gastric Carcinoma with Lymphoid Stroma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588277 |
| 699 | = | Gingival Squamous Cell Carcinoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588275 |
| 699 | = | Incidental Gallbladder Carcinoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588276 |
| 699 | = | Invasive Bladder Carcinoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588267 |
| 699 | = | Lung Non-Keratinizing Squamous Cell Carcinoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588271 |
| 699 | = | Mediastinal Lymphoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588268 |
| 699 | = | Non-Keratinizing Squamous Cell Carcinoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588269 |
| 699 | = | Ovarian Small Cell Carcinoma | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588272 |
| 699 | = | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 22 | 69.6 | Medium confidence | pubmed | inputs
ranking row 2588270 |
| 710 | = | Ameloblastic Carcinoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588285 |
| 710 | = | Breast Sarcoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588278 |
| 710 | = | Endometrioid Stromal Sarcoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588280 |
| 710 | = | Extraskeletal Myxoid Chondrosarcoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588281 |
| 710 | = | Follicular Dendritic Cell Sarcoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588279 |
| 710 | = | Hepatopancreatobiliary Carcinoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588282 |
| 710 | = | Mesonephric Adenocarcinoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588286 |
| 710 | = | Myelodysplastic Syndrome with Excess Blasts | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588283 |
| 710 | = | Myxoid Chondrosarcoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588289 |
| 710 | = | Ocular Adnexal Non-Hodgkin Lymphoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588284 |
| 710 | = | Plasmablastic Lymphoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588288 |
| 710 | = | Sinonasal Undifferentiated Carcinoma | 21 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2588287 |
| 722 | = | Aggressive NK-Cell Leukemia | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588291 |
| 722 | = | Biliary Tract Carcinoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588292 |
| 722 | = | Childhood Malignant Liver Neoplasm | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588293 |
| 722 | = | Childhood Pleomorphic Rhabdomyosarcoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588308 |
| 722 | = | Collecting Duct Carcinoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588309 |
| 722 | = | Extraskeletal Osteosarcoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588294 |
| 722 | = | Folliculotropic Mycosis Fungoides | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588311 |
| 722 | = | Indolent Adult Non-Hodgkin Lymphoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588303 |
| 722 | = | Iris Melanoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588295 |
| 722 | = | Liver Embryonal Sarcoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588304 |
| 722 | = | Low Grade Myofibroblastic Sarcoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588296 |
| 722 | = | Lung Mucosa-Associated Lymphoid Tissue Lymphoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588297 |
| 722 | = | Muscle Invasive Bladder Carcinoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588305 |
| 722 | = | Myxoid Liposarcoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588298 |
| 722 | = | Olfactory Neuroblastoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588299 |
| 722 | = | Pleomorphic Liposarcoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588300 |
| 722 | = | Pleomorphic Rhabdomyosarcoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588306 |
| 722 | = | Primary Cutaneous Diffuse Large B-Cell Lymphoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588310 |
| 722 | = | Primary Effusion Lymphoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588301 |
| 722 | = | Primary Intraocular Non-Hodgkin Lymphoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588302 |
| 722 | = | Superficial Basal Cell Carcinoma | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588307 |
| 722 | = | Yolk Sac Tumor | 20 | 68.6 | Medium confidence | pubmed | inputs
ranking row 2588290 |
| 744 | = | Adult Extraskeletal Myxoid Chondrosarcoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588321 |
| 744 | = | Childhood Intraocular Retinoblastoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588322 |
| 744 | = | Conjunctival Squamous Cell Carcinoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588315 |
| 744 | = | Embryonal Tumor with Multilayered Rosettes | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588312 |
| 744 | = | Eosinophilic Solid and Cystic Renal Cell Carcinoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588328 |
| 744 | = | Hairy Cell Leukemia | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588313 |
| 744 | = | Head and Neck Adenoid Cystic Carcinoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588316 |
| 744 | = | Intraocular Retinoblastoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588323 |
| 744 | = | Lentigo Maligna | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588317 |
| 744 | = | Malignant Adrenal Gland Neoplasm | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588318 |
| 744 | = | Malignant Odontogenic Neoplasm | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588314 |
| 744 | = | Non-Seminomatous Germ Cell Tumor | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588329 |
| 744 | = | Prefibrotic Primary Myelofibrosis | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588326 |
| 744 | = | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588324 |
| 744 | = | Sclerosing Epithelioid Fibrosarcoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588319 |
| 744 | = | Skull Base Chordoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588325 |
| 744 | = | Tonsillar Carcinoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588327 |
| 744 | = | Verrucous Carcinoma | 19 | 67.6 | Medium confidence | pubmed | inputs
ranking row 2588320 |
| 762 | = | Adult Extraskeletal Osteosarcoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588335 |
| 762 | = | Anaplastic (Malignant) Meningioma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588330 |
| 762 | = | B Lymphoblastic Leukemia/Lymphoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588331 |
| 762 | = | Chronic Leukemia | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588332 |
| 762 | = | CIC-Rearranged Sarcoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588336 |
| 762 | = | Endolymphatic Sac Tumor | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588337 |
| 762 | = | Gastric AFP-Producing Adenocarcinoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588341 |
| 762 | = | Liver Neuroendocrine Carcinoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588334 |
| 762 | = | Microcystic Adnexal Carcinoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588338 |
| 762 | = | Ovarian Carcinosarcoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588339 |
| 762 | = | Prostate Acinar Adenocarcinoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588340 |
| 762 | = | Undifferentiated Embryonal Sarcoma of the Liver | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588342 |
| 762 | = | Vulvar Melanoma | 18 | 66.8 | Medium confidence | pubmed | inputs
ranking row 2588333 |
| 775 | = | Adrenal Gland Neuroblastoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588361 |
| 775 | = | Alveolar Rhabdomyosarcoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588355 |
| 775 | = | Anorectal Melanoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588347 |
| 775 | = | Basaloid Squamous Cell Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588349 |
| 775 | = | Biphenotypic Sinonasal Sarcoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588350 |
| 775 | = | B Lymphoblastic Lymphoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588348 |
| 775 | = | Bone Mesenchymal Chondrosarcoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588351 |
| 775 | = | Cecum Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588368 |
| 775 | = | Childhood Mesenchymal Chondrosarcoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588356 |
| 775 | = | Chondroblastic Osteosarcoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588362 |
| 775 | = | Combined Lung Small Cell Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588357 |
| 775 | = | Dedifferentiated Chondrosarcoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588352 |
| 775 | = | Double-Expressor Lymphoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588363 |
| 775 | = | Gastric Adenocarcinoma of Fundic-Gland Type | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588366 |
| 775 | = | Glottic Squamous Cell Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588364 |
| 775 | = | High Grade Endometrial Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588365 |
| 775 | = | Juvenile Myelomonocytic Leukemia | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588344 |
| 775 | = | Melanoma with BRAF Mutation | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588353 |
| 775 | = | Plasma Cell Leukemia | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588345 |
| 775 | = | Platinum-Sensitive Ovarian Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588358 |
| 775 | = | Renal Pelvis Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588359 |
| 775 | = | Somatic-Type Malignancy | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588343 |
| 775 | = | Squamoid Eccrine Ductal Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588367 |
| 775 | = | Squamous Cell Carcinoma In Situ | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588354 |
| 775 | = | Testicular Germ Cell Neoplasia In Situ | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588369 |
| 775 | = | Transient Abnormal Myelopoiesis | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588370 |
| 775 | = | Transient Abnormal Myelopoiesis Associated with Down Syndrome | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588346 |
| 775 | = | Ureter Carcinoma | 17 | 66.2 | Medium confidence | pubmed | inputs
ranking row 2588360 |
| 803 | = | Adult Acute Erythroid Leukemia | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588380 |
| 803 | = | Adult B Lymphoblastic Lymphoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588381 |
| 803 | = | Adult Lymphoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588371 |
| 803 | = | Cecum Adenocarcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588388 |
| 803 | = | Central Nervous System Medulloepithelioma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588372 |
| 803 | = | Childhood Acute Erythroid Leukemia | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588382 |
| 803 | = | Childhood B Lymphoblastic Lymphoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588377 |
| 803 | = | Clear Cell Sarcoma of Soft Tissue | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588378 |
| 803 | = | EBV-Related Nasopharyngeal Squamous Cell Carcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588383 |
| 803 | = | Extranodal NK-/T-Cell Lymphoma, Nasal Type | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588392 |
| 803 | = | Granulocytic Sarcoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588373 |
| 803 | = | Head and Neck Sarcoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588374 |
| 803 | = | Hereditary Retinoblastoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588375 |
| 803 | = | Malignant Breast Phyllodes Tumor | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588376 |
| 803 | = | Pediatric-Type Follicular Lymphoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588386 |
| 803 | = | Pituitary Carcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588391 |
| 803 | = | Proximal Colon Carcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588389 |
| 803 | = | ROS1-Positive Lung Non-Small Cell Carcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588387 |
| 803 | = | Sigmoid Colon Adenocarcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588390 |
| 803 | = | Small Intestinal Lymphoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588384 |
| 803 | = | Tracheal Adenoid Cystic Carcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588379 |
| 803 | = | Urinary Tract Carcinoma | 16 | 65 | Medium confidence | pubmed | inputs
ranking row 2588385 |
| 825 | = | Acute Erythroid Leukemia | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588394 |
| 825 | = | Appendix Mucinous Adenocarcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588401 |
| 825 | = | Bladder Adenocarcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588413 |
| 825 | = | Breast Apocrine Carcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588414 |
| 825 | = | Breast Melanoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588393 |
| 825 | = | Breast Mucinous Carcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588402 |
| 825 | = | Chronic Eosinophilic Leukemia, Not Otherwise Specified | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588395 |
| 825 | = | Colorectal Mucinous Adenocarcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588403 |
| 825 | = | Cribriform Carcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588396 |
| 825 | = | Diffuse Midline Glioma, H3 K27-Altered | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588415 |
| 825 | = | Fusion-Positive Rhabdomyosarcoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588404 |
| 825 | = | Hepatosplenic T-Cell Lymphoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588405 |
| 825 | = | Hereditary Melanoma with CDKN2A Mutation | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588397 |
| 825 | = | High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588420 |
| 825 | = | Hyperdiploid B Lymphoblastic Leukemia/Lymphoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588406 |
| 825 | = | Intraductal Oncocytic Papillary Neoplasm | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588421 |
| 825 | = | Invasive Conventional Urothelial Carcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588407 |
| 825 | = | Lacrimal Gland Adenoid Cystic Carcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588408 |
| 825 | = | Liver Epithelioid Hemangioendothelioma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588409 |
| 825 | = | Lung Sarcoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588398 |
| 825 | = | Malignant Anorectal Neoplasm | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588410 |
| 825 | = | Malignant PEComa | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588399 |
| 825 | = | Malignant Rectosigmoid Neoplasm | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588416 |
| 825 | = | Medulloblastoma, SHH-Activated | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588411 |
| 825 | = | Nail Apparatus Melanoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588417 |
| 825 | = | Rectosigmoid Adenocarcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588418 |
| 825 | = | Skin Nodular Basal Cell Carcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588412 |
| 825 | = | Thymus Squamous Cell Carcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588400 |
| 825 | = | Urachal Adenocarcinoma | 15 | 64.1 | Medium confidence | pubmed | inputs
ranking row 2588419 |
| 854 | = | Appendix Goblet Cell Adenocarcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588441 |
| 854 | = | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588433 |
| 854 | = | B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588442 |
| 854 | = | Childhood Bone Sarcoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588423 |
| 854 | = | Choroid Plexus Carcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588424 |
| 854 | = | Colorectal Carcinoma with BRAF Mutation | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588447 |
| 854 | = | Cutaneous Spitz Melanoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588425 |
| 854 | = | Digestive System Mixed Adenoneuroendocrine Carcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588422 |
| 854 | = | Early Stage Pancreatic Ductal Adenocarcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588448 |
| 854 | = | EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588426 |
| 854 | = | Ganglioneuroblastoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588427 |
| 854 | = | Indolent B-Cell Non-Hodgkin Lymphoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588434 |
| 854 | = | Intramucosal Adenocarcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588428 |
| 854 | = | Myeloproliferative Neoplasm, Not Otherwise Specified | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588429 |
| 854 | = | Neck Squamous Cell Carcinoma of Unknown Primary | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588435 |
| 854 | = | Ovarian Small Cell Carcinoma, Hypercalcemic Type | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588443 |
| 854 | = | Pancreatic Neuroendocrine Carcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588430 |
| 854 | = | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588436 |
| 854 | = | Pulmonary Blastoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588437 |
| 854 | = | Sinonasal Adenocarcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588438 |
| 854 | = | Spinal Chordoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588439 |
| 854 | = | Spindle Cell Rhabdomyosarcoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588444 |
| 854 | = | Spindle Cell Squamous Carcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588431 |
| 854 | = | Succinate Dehydrogenase-Deficient Renal Cell Carcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588445 |
| 854 | = | Thyroid Carcinoma Arising in Struma Ovarii | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588432 |
| 854 | = | Urethral Adenocarcinoma | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588440 |
| 854 | = | Vulvar Paget Disease | 14 | 62.8 | Medium confidence | pubmed | inputs
ranking row 2588446 |
| 881 | = | Adult Systemic Anaplastic Large Cell Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588465 |
| 881 | = | Childhood Ewing Sarcoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588454 |
| 881 | = | Cutaneous Merkel Cell Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588455 |
| 881 | = | Gastric Cardia Adenocarcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588476 |
| 881 | = | Gastroesophageal Junction Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588466 |
| 881 | = | Hepatitis C Virus-Related Hepatocellular Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588467 |
| 881 | = | Hereditary Melanoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588450 |
| 881 | = | Human Papillomavirus-Independent Squamous Cell Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588456 |
| 881 | = | Inferior Vena Cava Leiomyosarcoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588477 |
| 881 | = | Intraductal Tubulopapillary Neoplasm | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588481 |
| 881 | = | Kidney Non-Hodgkin Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588457 |
| 881 | = | Lacrimal Gland Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588468 |
| 881 | = | Lip Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588469 |
| 881 | = | Liver Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588458 |
| 881 | = | Lung Epithelioid Hemangioendothelioma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588470 |
| 881 | = | Malignant Ovarian Germ Cell Tumor | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588451 |
| 881 | = | Malignant Solitary Fibrous Tumor | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588449 |
| 881 | = | Mixed Cellularity Classic Hodgkin Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588471 |
| 881 | = | Monophasic Synovial Sarcoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588472 |
| 881 | = | Nodal Marginal Zone Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588479 |
| 881 | = | Odontogenic Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588459 |
| 881 | = | Orbital Rhabdomyosarcoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588473 |
| 881 | = | Pancreatoblastoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588474 |
| 881 | = | Polymorphous Adenocarcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588480 |
| 881 | = | Primary Bone Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588460 |
| 881 | = | Primary Cutaneous Follicle Center Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588475 |
| 881 | = | Rhabdoid Tumor of the Kidney | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588452 |
| 881 | = | Sarcomatosis | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588478 |
| 881 | = | Sebaceous Carcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588461 |
| 881 | = | Secondary Central Nervous System Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588462 |
| 881 | = | Serous Adenocarcinoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588463 |
| 881 | = | Splenic Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588453 |
| 881 | = | Systemic Anaplastic Large Cell Lymphoma | 13 | 61.6 | Medium confidence | pubmed | inputs
ranking row 2588464 |
| 914 | = | Acute Megakaryoblastic Leukemia | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588485 |
| 914 | = | Adult Acute Myelomonocytic Leukemia | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588501 |
| 914 | = | AIDS-Related Lymphoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588486 |
| 914 | = | Alveolar Soft Part Sarcoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588487 |
| 914 | = | Breast Diffuse Large B-Cell Lymphoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588493 |
| 914 | = | Cervical Invasive Stratified Mucinous Adenocarcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588502 |
| 914 | = | Childhood Acute Myelomonocytic Leukemia | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588510 |
| 914 | = | Classic Kaposi Sarcoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588503 |
| 914 | = | Desmoplastic Small Round Cell Tumor | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588488 |
| 914 | = | Differentiated High Grade Thyroid Gland Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588504 |
| 914 | = | Distal Colon Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588511 |
| 914 | = | EBV-Related Lymphoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588489 |
| 914 | = | Eccrine Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588494 |
| 914 | = | Esophageal Neuroendocrine Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588490 |
| 914 | = | Follicular Helper T-Cell Lymphoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588505 |
| 914 | = | Gingival Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588506 |
| 914 | = | Hepatocellular Macrotrabecular Massive Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588495 |
| 914 | = | Infant Acute Lymphoblastic Leukemia | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588496 |
| 914 | = | Infant Leukemia | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588491 |
| 914 | = | Infant-Type Hemispheric Glioma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588507 |
| 914 | = | Lepidic Adenocarcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588497 |
| 914 | = | Malignant Gingival Neoplasm | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588498 |
| 914 | = | Malignant Tracheal Neoplasm | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588482 |
| 914 | = | Mediastinal Seminoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588499 |
| 914 | = | Myeloid Neoplasm Post Cytotoxic Therapy | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588483 |
| 914 | = | Parotid Gland Mucoepidermoid Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588512 |
| 914 | = | Pelvic Sarcoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588484 |
| 914 | = | Retroperitoneal Leiomyosarcoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588500 |
| 914 | = | Sclerosing Rhabdomyosarcoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588508 |
| 914 | = | Thymic Neuroendocrine Tumor | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588513 |
| 914 | = | Thyroid Gland Cribriform Morular Carcinoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588509 |
| 914 | = | Uterine Corpus Adenosarcoma | 12 | 60.2 | Medium confidence | pubmed | inputs
ranking row 2588492 |
| 946 | = | Adult Anaplastic Ependymoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588520 |
| 946 | = | Anaplastic Ependymoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588514 |
| 946 | = | Atypical Teratoid/Rhabdoid Tumor-MYC | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588537 |
| 946 | = | BCLC Stage C Hepatocellular Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588552 |
| 946 | = | Bladder Squamous Cell Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588538 |
| 946 | = | Brain Sarcoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588539 |
| 946 | = | BRCA Hereditary Breast Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588521 |
| 946 | = | Breast Paget Disease | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588540 |
| 946 | = | Cervical Small Cell Neuroendocrine Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588541 |
| 946 | = | Childhood Anaplastic Ependymoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588522 |
| 946 | = | Childhood Malignant Ovarian Germ Cell Tumor | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588523 |
| 946 | = | CIC-DUX4 Sarcoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588553 |
| 946 | = | Diffuse Hemispheric Glioma, H3 G34-Mutant | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588542 |
| 946 | = | Duodenal Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588554 |
| 946 | = | Embryonal Tumor with Multilayered Rosettes, C19MC-Altered | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588524 |
| 946 | = | Endocrine Mucin-Producing Sweat Gland Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588543 |
| 946 | = | Epithelioid Glioblastoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588544 |
| 946 | = | FH-Deficient Renal Cell Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588558 |
| 946 | = | Gray-Zone Lymphoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588545 |
| 946 | = | Hairy Cell Leukemia Variant | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588525 |
| 946 | = | Head and Neck Rhabdomyosarcoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588526 |
| 946 | = | Hereditary Ovarian Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588515 |
| 946 | = | Hereditary Renal Cell Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588527 |
| 946 | = | Infant Acute Undifferentiated Leukemia | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588546 |
| 946 | = | Invasive Plasmacytoid Urothelial Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588547 |
| 946 | = | Lung NUT Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588528 |
| 946 | = | Lymphangiosarcoma of Stewart and Treves | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588556 |
| 946 | = | Malignant Cardiac Neoplasm | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588516 |
| 946 | = | Malignant Intracranial Neoplasm | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588529 |
| 946 | = | Malignant Mixed Mesodermal (Mullerian) Tumor | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588517 |
| 946 | = | Malignant Peripheral Nerve Sheath Tumor | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588518 |
| 946 | = | Malignant Superior Sulcus Neoplasm | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588530 |
| 946 | = | Malignant Tonsillar Neoplasm | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588548 |
| 946 | = | Meningeal Melanoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588531 |
| 946 | = | Mesothelioma In Situ | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588519 |
| 946 | = | Parathyroid Cancer | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588557 |
| 946 | = | Pharyngeal Squamous Cell Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588549 |
| 946 | = | Primary Breast Angiosarcoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588550 |
| 946 | = | Salivary Gland Adenoid Cystic Carcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588551 |
| 946 | = | Sinonasal Sarcoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588532 |
| 946 | = | Telangiectatic Osteosarcoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588555 |
| 946 | = | Testicular Lymphoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588533 |
| 946 | = | Undifferentiated Carcinoma with Osteoclast-Like Giant Cells | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588534 |
| 946 | = | Urothelial Carcinoma In Situ | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588535 |
| 946 | = | Vulvar Adenocarcinoma | 11 | 58.8 | Medium confidence | pubmed | inputs
ranking row 2588536 |
| 991 | = | Adenocarcinoma In Situ | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588571 |
| 991 | = | Adult Brain Glioblastoma | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588580 |
| 991 | = | Adult T Acute Lymphoblastic Leukemia | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588581 |
| 991 | = | Amelanotic Melanoma | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588559 |
| 991 | = | Anal Melanoma | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588582 |
| 991 | = | Brain Glioblastoma | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588572 |
| 991 | = | Breast Solid Papillary Carcinoma | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588573 |
| 991 | = | Breast Tall Cell Carcinoma with Reversed Polarity | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588583 |
| 991 | = | Childhood Brain Glioblastoma | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588584 |
| 991 | = | Childhood Gliomatosis Cerebri | 10 | 56.8 | Medium confidence | pubmed | inputs
ranking row 2588593 |
Data updated 16 hours agoSource updated unknown2,294 eligible entities · inputs hash 6636ad9f834652e029647409